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Abstract
Prostate cancer is one of the most commonly diagnosed cancers in the western world,
accounting for nearly 30% of all male malignancies. Radiation treatment of such can-
cer has high success rates, and depends primarily on the physician’s ability to deliver
a conformal therapeutic dose to the tumour. This involves a process of treatment
planning, brachytherapy implantation, and post-implant dosimetric verification.
The conformity of the achieved dose distribution to the treatment plan strongly cor-
relates with the accuracy of seed implantation in a prostate brachytherapy treatment
procedure. Incorrect seed placement leads to both short and long term complications,
including urethral and rectal toxicity. The author presents BrachyView, a novel con-
cept of a fast intraoperative treatment planning system, to provide real-time seed
placement information based on in-body gamma camera data. BrachyView com-
bines the high spatial resolution of a pixellated silicon detector (Medipix2) with the
volumetric information acquired by a transrectal ultrasound (TRUS). The two sys-
tems will be embedded in the same probe so as to provide anatomically correct seed
positions for intraoperative planning and postimplant dosimetry in real time during
implantation. Dosimetric calculations are based on the TG-43 method using the real
position of the seeds.
The purpose of this thesis is to demonstrate the feasibility of BrachyView using the
Medipix pixel detector and a pinhole collimator to reconstruct the real-time 3D posi-
tion of low dose-rate brachytherapy seeds in a phantom. The design and geometry of
the system was optimised by means of Monte Carlo methods, verifying the truncated
ii
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cone design of the pinhole and thickness of lead collimator.
BrachyView incorporates Medipix detectors coupled to a multipinhole collimator.
Three-dimensionally triangulated seed positions from multiple planar images are
used to determine the seed placement in a PMMA prostate phantom in real time.
MATLAB codes were used to test the reconstruction method and to optimise the de-
vice geometry. The results presented in this thesis show a 3D position reconstruction
accuracy of the seed in the range of 0.5-3 mm for a 10-60 mm seed-to-detector dis-
tance range (Z direction), respectively. The BrachyView system also demonstrates a
spatial resolution of 0.25 mm in the XY plane for sources at 10 mm distance from
the Medipix2 detector plane, comparable to the theoretical value calculated for an
equivalent gamma camera arrangement. The author successfully demonstrated the
capability of BrachyView for real-time imaging (using a 3s data acquisition time) of
different brachytherapy seed configurations (with an activity of 0.05 U) in a PMMA
prostate phantom.
Following this, additional experimental studies involving 20 active I-125 seeds ver-
ified the applicability of BrachyView as a real-time intraoperative imaging system
for prostate LDR brachytherapy. Seed positions were co-registered with a clinical
CT scan, showing accuracy within 1-3mm of expected positions. Finally, the multi-
modality imaging capabilities of the BrachyView system were evaluated in both CT
and X-ray transmission imaging, making use of a microfocus X-ray tube and tissue-
equivalent prostate phantoms.
The newly developed miniature gamma camera component of BrachyView, with its
high spatial resolution and real time capability, allows accurate 3D localisation of
implanted sources in a prostate phantom. Combination of the gamma camera with
the transrectal ultrasound in a single probe will complete the BrachyView system.
This thesis addresses issues of ionising radiation detection in cancer therapy, leading
to seed position determination and object imaging.
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Chapter 1
Introduction
Prostate cancer is the highest occurring cancer in Australian males. With early de-
tection however, treatment has a high success rate by either surgical techniques or
radiation therapy. Recently, the use of permanent radioactive implants has grown to
become a popular choice for men facing prostate cancer. This technique is known as
brachytherapy.
Permanent prostate brachytherapy (PPB) consists of the permanent implantation of
low energy radioactive sources directly into the patient’s prostate. This technique
is typically guided by transrectal ultrasound imaging in conjunction with X-ray fluo-
roscopy and post-implant CT scans. However, the nature of these imaging techniques
do not allow for adjustments during implant in cases of poor dosimetry or tumour and
gland coverage. The location of these brachytherapy seeds is the largest contributor
to dosimetric error, and therefore clinical treatment outcome.
In the brachytherapy community, there has been recent discussion concerning the use
of real-time intraoperative treatment planning techniques based on real-time imaging.
Some investigations have been undertaken to implement real-time imaging systems
for brachytherapy implant guidance. To date, no system exists that is robust and
cost-effective for widespread use.
By utilising the novel semiconductor detector Medipix (and later generation Timepix)
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coupled with a unique pinhole camera system, BrachyView is proposed by CMRP
as an in-body imaging device capable of providing real-time seed localisation. This
would allow a real-time optimisation of the implant, thereby ensuring maximal dose
coverage of the tumour and treatment outcome.
The application of Timepix also opens up the possibility of other imaging modalities
such as CT and soft tissue diagnostic imaging, suggesting the use of BrachyView as
an ultra-functional, multi-modality imaging device for the effective management of
the brachytherapy procedure.
1.1 Objectives, Overview and Summary of Contribu-
tions of this Thesis
The objectives of this thesis are as follows:
• Develop a novel imaging and dose planning system for low dose rate prostate
brachytherapy implant treatments;
• Use high-resolution Timepix detectors for imaging of implanted I-125 brachyther-
apy implants;
• Test a pinhole system coupled with aforementioned Timepix detectors in ac-
curactely localising sources within three-dimensions;
• Propose an intraoperative dynamic dosimetric system to optimise patient out-
comes by avoiding critical structures surrounding the prostate anatomy;
• Test the applicability of Timepix for use in tomographic measurements for
post-implant dosimetric checks;
• Present BrachyView as a unique, ultra-functional imaging probe, with capabil-
ity for multiple modalities in imaging.
The Thesis is divided into the following chapters:
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• Chapter 1 presents an introduction to the main topics covered in the Thesis;
• Chapter 2 presents a comprehensive review of relevant literature, outlining the
history and modern practices of prostate brachytherapy;
• Chapter 3 presents a detailed description of the proposed novel detector assem-
bly for use in BrachyView;
• Chapter 4 presents the analytical and simulation models used to optimise the
pinhole collimator characteristics used in experimental work;
• Chapter 5 presents a detailed description of the pinhole used in experimental
phantom studies for proof of concept studies in BrachyView. Using this pin-
hole system, LDR seed localisation was performed. This work resulted in the
following publications and presentations:
K.J. Loo, M. Petasecca, Z. Han, D.L. Cutajar, M. Weaver, M. Lerch, P.E. Met-
calfe, S. Meikle, S. Pospisil, J. Jakubek, J.A. Bucci, M. Zaider, A.B. Rosen-
feld, BrachyView: In-prostate real time seed position imaging for prostate
brachytherapy using Medipix camera, 20th Annual Australasian Brachyther-
apy Group Meeting, 2011
K.J. Loo, M. Safavi, M. Lerch, Z. Han, J. Jakubek, S. Pospisil, S. Meikle,
M. Zaider, J. Bucci, A.B. Rosenfeld, BrachyView: A novel in-body imaging
system for prostate brachytherapy, Nuclear Science Symposium and Medical
Imaging Conference (NSS/MIC) 2011 IEEE, pp. 279-281, 2011
M. Petasecca, K.J. Loo, Z. Han, P.E. Metcalfe, S. Meikle, S. Pospisil, J. Jakubek,
J.A. Bucci, M. Zaider, M.L. Lerch, Y. Qi, A.B. Rosenfeld, BrachyView: proof-
of-principle of a novel in-body gamma camera for low dose-rate prostate brachyther-
apy, Medical Physics, vol. 40, no. 4, 2013
• Chapter 6 presents experimental and analytic work performed to evaluate the
application of Timepix detectors in CT reconstruction of implanted LDR seeds.
This work resulted in the following publications and presentations:
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K.J. Loo, M. Petasecca, M. Safavi-Naeini, Z. Han, BrachyView: Tomographic
reconstruction using Timepix detectors in post-implant dosimetry checks for
permanent prostate brachytherapy implants, Nuclear Science Symposium and
Medical Imaging Conference (NSS/MIC) 2013 IEEE, pp. 1-3, 2013
• Chapter 7 presents experimental work performed with Timepix for evaluation
of soft tissue diagnostic imaging using a medical tissue-equivalent prostate gel
phantom. This work resulted in the following publications and presentations:
K.J. Loo, J. Jakubek, J. Zemlicka, M. Petasecca, M. Safavi-Naeini, J. Bucci,
M. Zaider, A.B. Rosenfeld, Feasibility study into the application of Timepix
detectors for soft tissue thickness imaging in prostate brachytherapy treatment,
Radiation Measurements, vol. 71, pp. 329-332, 2014
1.2 Presentations and Invited Talks
This work has been presented at the following conferences and meetings:
• 2010
– Australian Rotary Health PhD Scholars Dinner, Parramatta City, Aus-
tralia, June 7: invited talk.
• 2011
– Australian Rotary Health District Conference, Bathurst, Australia, March
18: invited talk.
– 20th Annual Australasian Brachytherapy Group Meeting, Perth, Aus-
tralia, April 28-30: oral presentation.
– Australian Rotary Health PhD scholars Dinner, Parramatta City, Aus-
tralia, May 9: invited talk.
– Rotary Club of Berrima District Lunch, Berrima, Australia, July 6: in-
vited talk.
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– IEEE Nuclear Science Symposium and Medical Imaging Conference, Va-
lencia, Spain, October 23-29: poster presentation.
• 2012
– 21st Annual Australasian Brachytherapy Group Meeting, Canberra, Aus-
tralia, March 1-3: oral presentation.
– Australian Rotary Health District Conference, Wollongong, Australia,
March 18: invited talk.
– World Congress on Medical Physics and Biomedical Engineering, Bei-
jing, China, May 26-31: oral presentation (by Prof. Anatoly Rosenfeld).
– 1st Annual ARDENT Workshop, Vienna, Austria, November 20-23: oral
presentation.
• 2013
– HSC Physics class, Illawarra Christian School, Cordeaux Campus, Wol-
longong, Australia, April 9: oral presentation.
– Australian Rotary Club meeting, Parramatta, Australia, April 15: oral
presentation.
– ARDENT Meeting, Geneva, Switzerland, June 13: oral presentation.
– HSC Physics class, Kirawee High School, Sydney, Australia, September
2: oral presentation.
– 17th Annual Conference on Solid State Dosimetry, Recife, Brazil, Septem-
ber 22-27: poster and oral presentation.
– IEEE Nuclear Science Symposium and Medical Imaging Conference,
Seoul, South Korea, October 27-November 2: two oral presentations.
– 2nd Annual ARDENT Workshop and Mid-Term Review, Milan, Italy,
October 14-18: oral presentation.
– National Radiation Protection Institute (SURO), Prague, Czech Republic,
November 20: invited talk.
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– Marie Curie Actions: Horizon 20/20, Florence, Italy, November 26-27:
invited talk.
• 2014
– 3rd Annual ARDENT Workshop, Burgthann, Germany, September 30:
oral presentation.
• 2015
– IBA Dosimetry, Memphis, USA, February 11: oral presentation.
– 4th Annual ARDENT Workshop, Prague, Czech Republic, June 22: oral
presentation.
– 4th Annual ARDENT Workshop Outreach Program, Prague, Czech Re-
public, June 24: oral presentation.
1.3 Funding Support and Awards
This work was supported by the Australian National Health and Medical Research
Council (NHMRC) under Development Grant 1000557 entitled ”A new multifunc-
tional probe for in-body radiation imaging and dosimetry during brachytherapy treat-
ment of prostate cancer”, which is a collaboration between the University of Wollon-
gongs Centre for Medical Radiation Physics (lead investigator Prof Anatoly Rosen-
feld), the Czech Technical University’s Institute of Experimental and Applied Physics
(Dr Jan Jakubek), St George Cancer Care Centre (Dr Joseph Bucci), the University
of Sydney’s Brain & Mind Research Institute (Dr Steven Meikle), and Memorial
Sloan-Kettering Cancer Center (Prof Marco Zaider).
This research was also supported by the Australian Rotary Health Foundation for a
research topic involving prostate cancer. Between 2010 and 2012, this scholarship
was awarded by the Rotary Club of Parramatta City (Rotary District 9680).
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In 2011, the work conducted as outlined in Chapter 5 was awarded the IEEE Nu-
clear Physics and Plasma Science (NPSS) Phelps Educational Grant. This award
was for ”exceptional promise as a graduate student in any of the fields of the NPSS,
exceptionally good work in those fields”. In 2012, this work was awarded the best
presentation in the university-wide speaking contest 3 Minute Thesis and was taken
to the Trans-Tasman finals held at the University of Queensland.
In 2013, this research received continued support through the ARDENT (Advanced
Radiation Dosimetry European Network Training) program. The ARDENT Marie
Curie Initial Training Network (ITN) is an international collaboration across 8 in-
ternational institutes, and funded by CERN (Geneva, Switzerland). This is a 3 year
research contract (commenced February 2013) part of which this Thesis is a deliver-
able.
Chapter 2
Literature Review
This Chapter presents a comprehensive review of literature related to prostate cancer
and brachytherapy treatments. Section 2.1 highlights the incidence rates of prostate
cancer in Australia, detailing the rising problem to men’s health that cancer poses.
Section 2.1.2 explains the treatment options available for men who opt for radi-
ation therapy, including details on isotope use. Section 2.2 presents the history
of prostate brachytherapy, in particular the advent of ultrasound-guided imaging
proposed by Holm et al. Section 2.2.3 explains the use of ultrasound imaging in
modern brachytherapy procedures and Section 2.3 details the different approaches
brachytherapy practitioners use for treatment planning, including the debate of the
traditional pre-planned technique versus intraoperative planning. Section 2.4 ex-
plains the importance of dosimetric analysis and the correlation with treatment out-
come for prostate cancer patients. Section 2.5 presents the various methods used and
tested for real-time seed localisation. Section 2.6 introduces the Timepix detector
as a viable option for application in real-time imaging of the PPB implant. Section
2.7 details the use of pinholes in a novel ’gamma camera’ mode in conjunction with
the Timepix detectors as the basis of the BrachyView system. Finally, Section 2.8
presents a summary of the main concepts covered in this Chapter and their implica-
tions for the experimental work carried out in this Thesis.
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Figure 2.1 Cancers in males according to National Cancer Statistics Clearing House, AIHW.
2.1 Prostate Cancer in Australia
Prostate cancer is widely regarded internationally as one of the most prevalent prob-
lems in today’s radiation oncology community. In 2012, it is estimated that 120,710
new cases were diagnosed with more than half (56%) of all cancers diagnosed in Aus-
tralian males. The most commonly diagnosed cancers in males was prostate cancer
accounting for 27% of all male cancers diagnosed, and is in fact the most common
cancer in overall statistics. The next most common cancer, bowel cancer with 8,760
new diagnoses, had less than half the prostate statistic. The next three most com-
mon cancers were skin melanoma (7,440), lung cancer (6,620) and non-Hodgkin
lymphoma (2,620) (19).
In 2012, it is estimated that 1 in 3 males were diagnosed with cancer by the age of
75, increasing to 1 in 2 by age 85. The risk is highest for prostate cancer, estimated
at 1 in 8 before the age of 75, and 1 in 6 by age 85. The overall trend for prostate
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Cancer site 2006 2007 2008 2009 2010
Colorectal 7,448 7,644 7,827 8,015 8,209
Skin melanoma 6,143 6,383 6,625 6,875 7,135
Prostate 16,011 16,923 17,835 18,784 19,775
Table 2.1
Annual rates of incidence for Australian men based on Australian Institute of Health and
Welfare statistics. (19)
Figure 2.2 Trends in incidence of prostate cancer in males, Australia, 1991 to 2009, with
estimates to 2012
cancer has been a gradual increase with some fluctuations in more recent years.
The peaks in prostate cancer rates are thought to be caused by changes in cancer
screening and detection rather than an elevated risk of disease. PSA (prostate-specific
antigen) testing first became available in 1987 and was first listed in the Medicare
Benefits Schedule in 1989, accounting for the peak in the earl 1990s. The second
recent rise in incidence numbers is a result of other changes in diagnostic proce-
dures such as lowering the investigation threshold. Nonetheless, the incidence rate
of prostate cancer is consistently high and the risk is ever-growing for Australian
men.
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Figure 2.3 Causes listed are the leading causes of death for all deaths registered in 2011,
based on WHO recommended tabulation of leading causes.
While being the most common cancer in Australian men, prostate cancer is the sec-
ond most common cause of cancer-related deaths as discussed in Section 2.1.1.
2.1.1 Prostate Cancer Mortality in Australia
According to the Australian Bureau of Statistics (21) prostate cancer consistently
ranks in the top 20 leading causes of death in Australia based on data evalation meth-
ods presented in the Bulletin of the World Health Organisation (22).
From a total of 22,421 deaths from cancer in males in 2010, the most common was
lung cancer (4,934), followed by prostate cancer (3,3235) and bowel cancer (2,205).
From a total of 22,017 deaths from cancer in males in 2005, the most common was
lung cancer (4,711 deaths), followed by prostate cancer (2,949). Colorectal cancer
(2,322), unknown primary site (1,829) and pancreatic cancer (964) comprise the oth-
ers. These accounted for 58% of all deaths from cancer in males.
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Statistics released for 2008 by the ABS are such that of a total of 42,418 registered
cancer-related deaths in Australia occurred. In 2008, prostate cancer was the cause
of 3,031 registered deaths, which accounts for 4.1% of all male deaths. The median
age at death for prostate cancer was 81.0 years. This is close to the median age for all
male deaths (77.9 years). Potential life lost from deaths due to prostate cancer was
9,178 years.
2.1.2 Treatment Options
The treatment options for prostate cancer include radical prostatectomy (RP), exter-
nal beam radiation therapy (EBRT), hormonal therapy (androgen deprivation therapy,
or ADT), watchful waiting, and temporary and permanent brachytherapy (permanent
prostate brachytherapy, or PPB). The relative efficacy of each method is a matter
of some contention but since the 1980s, permanent brachytherapy has moved to the
forefront.
Brachytherapy involves the insertion of radioactive sources directly into the affected
organ, rather than delivering through EBRT. These sources are usually smaller than 5
mm in length and when deployed in an array their net effect is to deliver a therapeutic
cloud of radiation to the affected organ. Some common areas where brachytherapy
is used include the eye, breast, some skin and brain, and the prostate.
From a clinical standpoint, brachytherapy is a simple outpatient procedure that avoids
the need for hospitalisation and allows rapid recovery and return to normal activity.
It has also produced excellent 10-year patient outcomes as reported by Nag et al
(23). As opposed to EBRT, which can take up to 6 weeks to complete, brachytherapy
patients can return home after one or two days of treatment.
Brachytherapy utilises radioactive sources like iodine-125 (I-125) or palladium-103
(Pd-103), which allow dose escalation within the prostate with a rapid dose fall-off
(steep dose gradient) in surrounding healthy tissues.
There are two options in prostate brachytherapy. These are either low dose rate
Literature Review 13
Figure 2.4 Brachytherapy sources implanted in prostate. Image courtesy of Mount Nittany
Health.
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Principle Radionuclide I-125
Radionuclide purity I-125 > 99.9%
I-126 < 0.005%
Half-life 59.43 days
Energy level X-ray 27.4 keV
X-ray 31.4 keV
Gamma 35.5 keV
Fluorescent X-rays from
Ag rod
22.1, 25.2 keV
Table 2.2 Physical properties of the I-125 seeds as presented by Oncura.
(LDR) or high dose rate (HDR). In this thesis, we will discuss the development of a
novel imaging technique for PPB LDR, which relies mainly on the use of the I-125
radioisotope.
2.1.2.1 I-125 as Radioactive Source
I-125 sources are the most common source used in LDR brachytherapy. I-125 has a
half-life of 59.4 days and a relatively low peak energy of 28.3 keV, consisting of a
series of peaks ranging from 22.1-35.5 keV. The low energy is important for its steep
dose gradient and ease of shielding. I-125 is also easily produced in medium flux
nuclear reactors. Because of these favourable characteristics, I-125 seed sources are
considered to be one of the best isotopes for use in prostate brachytherapy and is the
premier choice for centres in Australia and the United States. It is also used in eye
and breast brachytherapy procedures. There is a wide range of seed designs available
but one of the most common choices is the 6711 model: Nycomed-Amersham 6711
(OncoSeed), as shown in Figure 2.7.
The seeds themselves consist of I-125 deposited on the surface of a silver core and
encased within a titanium cylinder. They are 4.5 mm in total length and have an
active length of 3 mm. The specific physical properties of the seed are outlined
in Table 2.2. I-125 decays by electron capture with the emission of characteristic
photons and electrons. The electrons are absorbed in the titanium wall.
Seeds with total apparent activity from 0.191 to 1.01 mCi (usually 0.4 mCi) are
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Figure 2.5 Decay scheme of I-125 showing electron capture and a maximum photon energy
emission of 35 keV.
Figure 2.6 Radiations emitted in the Decay of I-125.
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Figure 2.7 Model 6711 I-125 seed schematic by Oncoseed (1)
.
used for permanent interstitial implantation of selected localised tumours with low
to moderate radiosensitivity. These are used either as primary treatment (such as
in prostate cancer) or for treatment of residual disease after excision of the primary
tumour. Anywhere between 80-120 seeds are typically implanted directly into the
gland according to preplanning volume studies and dosimetric requirements for ef-
fective dose distribution. Apart from prostate cancer, tumours of the head, neck,
lung, pancreas and the eye are also commonly treated by brachytherapy techniques.
One of the main dosimetric issues to consider in brachytherapy implants is source
localisation.
Ir-192 is another commonly used source in brachytherapy procedures, but with sep-
arate application in HDR procedures.
2.1.2.2 Ir-192 as Radioactive Source
HDR treatment utilises a high-activity source such as Ir-192 to irradiate the prostate
gland and tumour in a technique known as afterloading. Ir-192 differs greatly from
the I-125 source introduced in Section 2.1.2.1 with a mean photon energy of 0.38
MeV and half-life of 73.8 days by beta decay. Furthermore, rather than being inserted
surgically, the implant is only temporary with high-dose exposure is also achieved.
Literature Review 17
HDR techniques are typically used as booster treatments in conjunction with EBRT
(also known as combined modality, as opposed to monotherapy).
Once the catheters have been implanted into the prostate and through the applica-
tor template, the patient is moved to a specially shielded room for HDR treatment.
Following CT-based treatment planning, in which the catheter positions are verified,
several high dose fractions ranging from 4-6 Gy each are administered over 1-3 days.
In the case of HDR monotherapy, a typical recommended dose is around 40 Gy deliv-
ered in fractions. The American Brachytherapy Society suggests 10.5 Gy×3, 8.5-9.5
Gy×4, or 6.0-7.5 Gy×6 fractions.
The radiation is delivered by an afterloader apparatus. The source is positioned with
specific dwell times and source locations according to the treatment plan. Source
dwell positions are selected by suitable and accurate mechanical extension of the
length of the thin transport cable, to which the source is attached. The Ir-192 source
is moved into successive needles by inserting and withdrawing the cable (see Figure
2.8).
Only a single source is used as it is moved through each catheter by the afterloader.
HDR treatment is usually followed by EBRT to the prostate and periprostatic tissues
to a dose of approximately 50 Gy using conventional techniques (24).
HDR therapy is only suitable for cases where the tumour is well localised and rela-
tively small. While the source is different to that in LDR treatment, the dosimetric
goal remains the same such that the technique is based on ultrasound imaging and
online calculations of dose distribution- live planning that consists of updating nee-
dle position based on dose parameters. Ideally, a homogeneous radiation field should
exist around the catheters inserted into the prostate volume and conform to the target
volume, and if possible, a cold spot (low dose area) around the urethra.
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Figure 2.8 (left) MicroSelectron HDR afterloading unit. (Right) Catheters shown connecting
the channel sockets in the 18-channel treatment head of the MicroSelectron unit with the
needles inserted in the patient (2).
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2.2 Brachytherapy for Prostate Cancer
The basic underlying principle across the literature and all research in brachyther-
apy is to deliver more radiation dose to the tumour and less to the surrounding nor-
mal tissues in an ongoing effort to improve the therapeutic ratio for prostate cancer
treatment (25). Zerbib et al. (20) state that ”the optimal treatment strategy for a
patient with prostate cancer should provide long-term disease control with minimal
treatment-related morbidity and maximal preservation of quality of life”. Choice of
treatment strategies change with time as evident in the two decades since the 1980s,
where there has been a significant decrease in watchful waiting (active surveillance)
and RP procedures, whilst accompanied by a marked increase in brachytherapy and
primary androgen deprivation therapy.
In watchful waiting, patients with low-risk tumour characteristics are actively moni-
tored without sacrificing risk of cure or unnecessary disease progression. Radiother-
apy options are either external beam radiotherapy (EBRT) or brachytherapy.
There is substantial evidence as quoted by Zerbib et al that greater radiation doses
are critical to achieve optimal tumour control for patients with clinically localised
diseases.
EBRT is an effective, non-invasive form of radiotherapy but comes with long-term
risks of troublesome bowel, sexual and urinary dysfunction. It is also considered
too aggressive for low-risk cancers. For higher-grade cancers, local recurrence after
radiotherapy carries substantial morbidity and low rates of long-term cancer control.
The choice of treatment is best done on a patient-to-patient basis depending on size
and grade of the gland and tumour. There is evidence that brachytherapy has greater
ablative potential on the prostate epithelium with greater long-term biochemical tu-
mour control, but only in low-risk patients (26; 27). Most notably, Zelefsky et al.
(28) recommend brachytherapy be considered the premier option for such patients.
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Advantages Disadvantages
Excellent cancer control rates Need for anaesthesia
Good correlation between focal plan-
ning target volume and dose distribu-
tion
Patients with larger prostate volume
require Androgen Deprivation Ther-
apy (ADT)
Option for real-time dosimetry Technically challenging procedure
with high operator-dependence
Can focally treat anterior prostate PSA level unlikely to decrease to 0
ng/mL, even after successful therapy
Low risk of urinary incontinence and
long-term incontinence and rectal mor-
bidity
Risk of irritative urinary symptoms or
retention
Other urinary and sexual morbidities
are treatable
Risk of prostatis and proctitis
Convenient and logistically simple After treatment failure, additional lo-
cal therapy associated with increased
risk of morbidity
Quality-of-life impairment (sexual,
urinary and rectal function)
Table 2.3 Clinical advantages and disadvantages of prostate brachytherapy (20)
Brachytherapy is a convenient, effective form of radiotherapy for clinically confined
cancer. However, favourable outcomes require meticulous technique. Acute urinary
symptoms are frequent and long-term risks of proctitis and erectile dysfunction are
comparable to the risks associated with EBRT.
Some of the advantages and disadvantages of brachytherapy according to Zerbib
et al. (20) are shown in Table 2.3.
Brachytherapy is a rapidly evolving treatment option and advances in imaging de-
vices are continuously being exploited. New technology to assist in implantation and
to improve dose distribution and accuracy are being developed and should help to
enhance the quality and consistency of implants.
Prostate cancer treatment by brachytherapy implants has had a controversial histor-
ical development in the radiation oncology community. The favoured technique as
developed by Whitmore in 1972 was the retropubic approach. Prior to this, local ap-
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plication of radium sources had been used since the early 20th century. These early
techniques generally involved insertion of needles transperineally under digital guid-
ance (physical palpatation). Other applications including urethral or rectal sources
were also introduced. However, with the advent of the modern linear accelerator,
external beam therapy became the primary modality of prostate irradiation (29).
A review paper of 18,000 studies by Grimm et al. (3) between 2000-2010 also in-
dicated that brachytherapy has the highest rates of biochemical survival, although
they do concede that this is partly due to patient selection criteria. The results for
intermediate-risk patients, highlighting brachytherapy’s success, is shown in Figure
2.9.
2.2.1 History: The Retropubic approach
In the early days of brachytherapy, a retropubic approach was used. This is where an
abdominal incision is made and the prostate exposed for manual implantation of the
I-125 seeds. From an appropriate volume study the total radiation dose and hence
the number of seeds required is calculated and implanted through needles. The seed
spacing in the needles is determined by dosimetry calculations. This technique was
developed and popularised at Memorial Sloan-Kettering Cancer Center (MSKCC,
New York) (30).
However, follow-up of patients treated by this method showed a biochemical disease-
free rate of only 13% at 5 years. This failure of this technique was concluded to arise
from imprecise placement of the seeds within the prostate due to the ’free-hand’
manual approach.
There were several procedural and dosimetric limitations to consider:
1. Overly simplified and idealised nature of the volume nomogram;
2. The actual shape of an individual’s prostate does not conform to the idealised
ellipsoid;
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Figure 2.9 The results from the study by Grimm et al. (3) showing prostate-specific antigen
(PSA)-free progression for different treatment options. Each standard deviational ellipse
(SDE) represents 1 SD about the weighted mean where data points were weighted by the
natural logarithm of the number of patients in the study. A minimum of four data points was
required in order to calculate an SDE. Each number corresponds to the specific study and its
cohort of patients studied [table not shown]. Key: Brachy, brachytherapy; HDR, high dose
radiotherapy; ADT, androgen deprivation therapy; Cryo, cryotherapy; HIFU, high intensity
focused ultrasound.
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3. Value of calculated dose did not depend upon actual radiation source distribu-
tion. (30)
As a result of the inhomogeneity of the implanted seeds, both well and poorly dis-
tributed seeds could actually yield the same value for tumour dose. This is a less-
than-ideal clinical situation as it inevitably resulted in areas of underdosage or cold
spots within the gland predisposing to local failure.
Zelefsky and Whitmore (31) performed an historical review of 1,078 patients be-
tween March 1970 and December 1987 treated with permanent implantation of iodine-
125 via Whitmore’s retropubic approach. Of these patients, 639 (59%) experienced
local relapse within a median of 47 months. A total of 598 patients (56%) had distant
metastases within a median of 45 months. The overall disease-free survival rates at 5,
10 and 15 years were 81, 41 and 12% respectively. Ultimately, the long-term results
demonstrated that the retropubic approach for I-125 implantation was not effective
as a therapeutic option when compared to other modalities.
Significantly better results were observed in patients who received doses of 140 Gy or
more and it was concluded that ”achieving the optimal dose distribution and tumour
dose is necessary for a high likelihood of tumour eradication”. A major contributing
factor to this is the source distribution and the adequacy of implant dosimetry. The
high incidence of local failure highlighted the limitations of this technique, resulting
in suboptimal distribution of the isotope within the prostate.
The advent of transperineal CT and ultrasound guided permanent prostatic implan-
tation has led to dramatic improvements in the accuracy of isotope placement and
thus better control of early stage localised disease. These long-term results closed
the chapter on I-125 implantation via the retropubic approach, but opened up new
treatment directions.
Conceptually, the open implant had great appeal by delivering a highly confined dose
within the prostate and the application of this concept still remains relevant today.
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According to Korb and Brawer (32), such hand-based techniques resulted in ”erratic
dose distributions”, resulting in hot and cold spots in the prostate. This led to an ”un-
acceptable rate of local failure”. Consequently, brachytherapy declined in popularity
from the 1960s onwards.
2.2.2 Holm’s Transrectal Ultrasound-guided Technique
Following the failure of the retropubic approach, a new system was developed. This
was via transperineal implantation of the radiation needles, first introduced by Bar-
ringer in 1917. This approach depended on digital (i.e. palpation by finger) guidance
through the rectum. It was self-evident that this technique did not provide adequate
information for an effective dose delivery. Holm et al. (5) proposed a technique in
1990 utilising ultrasound-guided percutaneous implantation. Many of the errors as-
sociated with early brachytherapy techniques, most notably the risks of open surgery
and lack of dose distribution information, were overcome with this novel ultrasound-
guided technique (4).
Planning is performed by transrectal ultrasound scanning in the dorsal lithotomy po-
sition. The scanner is mounted in a fixture apparatus and transverse scans obtained
at 5 mm intervals. The series of scans is used by the physicist and physician to con-
tour the relevant tumour and gland volumes, and thus to calculate the number and
distribution of seeds required to deliver a minimum peripheral tumour dose of 160
Gy (modern techniques typically aim for a tumour dose of approximately 145 Gy).
When the implant procedure is carried out, care is taken to place the scanner at ex-
actly the same position as during the planning procedure, especially with respect to
the distance between the rotational point of the scanner and the prostate’s posterior
aspect. The seed implantation technique is shown in Figure 2.10.
Needle tip position is verified by a strong echo reflection on the ultrasound image.
The central needles are inserted first, emptied and removed individually. The scanner
is withdrawn to the next image plane (usually 5 mm) and the procedure repeated until
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Figure 2.10 Technique of seed application: Needle loaded with seeds (1) and spacers is
inserted through template attachment (2) to the correct depth. The needle is then withdrawn
leaving seeds in place (3). The TRUS probe (4) verifies the location of implanted seeds (5)
in the prostate in real time.
the prostate is filled with seeds according to the radiotherapy planning program. Seed
position is verified by anterio-posterior and lateral X-rays, which yield the relevant
geometrical data for calculation of resulting dose distribution.
Holm’s study is not to evaluate the efficiency of brachytherapy in patients with pro-
static cancer but to introduce and describe a new technique for interstitial seed place-
ment. The improvements on the existing technique cover fundamental concepts in
prostate brachytherapy. The advantages are listed as follows:
1. The patient is spared the inconvenience and risk of open surgery (major oper-
ative complications may be in the order of 15 per cent);
2. The precise series of prostate ultrasound sectional images allows for a much
more detailed method for dose planning;
3. The simple needle-stylet system for insertion of seeds is efficient. (The modern
equivalent is by template guidance);
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Figure 2.11 Image showing TRUS being inserted into rectal cavity for brachytherapy needle
guidance. (4)
4. Because of the fixed ultrasonic guiding system, the seeds are inserted much
more precisely and distributed much better than by free-hand technique.
Since 1983, technological advances in computing and imaging technology have fur-
thered the physician’s ability to produce excellent results. However, the aim has been
the same through the years. That is, to continually improve the accuracy of seed
placement and imaging and planning techniques for improvements in dose planning
and dose homogeneity.
For example, one of the earlier steps in ultrasound-guided implantation was the de-
velopment of biplanar imaging as described by (5). Exclusive transverse imaging
(perpendicular to the long axis of the probe) does not allow for corrections for any
superior displacement of the prostate during implantation.
An example of an ultrasound system is shown in Figure 2.12. A Bruel & Kjaer
ultrasound system 1846 is employed, with a multiplanar 7 MHz ultrasound probe
type 8551. The single crystal produces a 112o sector image, and the scanning plane
can be rotated 180o to view all image planes. The ultrasound probe is described as
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Figure 2.12 (Left) Principle of multiplanar scanning. Top: crystal sweeps back and forth
in longitudinal mode. Bottom: crystal sweeps from side to side in transverse mode; (Right)
Principle of multiplanar imaging during transperineal needle insertion. The needle is inserted
into the prostate. Any needle can be visualised in all planes between and including transverse
and longitudinal. (5)
follows:
Over the past two decades, advances in imaging and computing technology have led
to sophisticated, ubiquitous, and three-dimensional sectional image-based treatment
planning. Included in this process are aspects such as 3D assessment of anatomy,
planning target volume and critical organ contouring, 3D dose calculations with dose
volume histograms and different forms of 3D display capabilities.
2.2.3 Modern Techniques for Prostate Seed Brachytherapy
In its most basic form, prostate brachytherapy involves four key steps:
1. Pretreatment patient evaluation, which includes PSA screening, assessment of
cancer stage and grade and extent of life risk;
2. Prostate volume determination (ultrasound volume study) and implant plan-
ning;
3. Seed insertion;
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4. Post-procedural evaluation of implant quality.
Sectional imaging (part of steps 2 and 3) has been the main driving force behind
prostate brachytherapy’s push to the forefront of prostate radiation therapy, ”in par-
ticular because the appropriate positioning of the seeds or needles could be improved
by avoiding too large distances between the sources on the one hand, and by selec-
tively sparing the urethra and the anterior rectal wall on the other hand” (6). Im-
ages are not only used for treatment planning, but also for direct guidance of the
application- image-assisted quality control of dose delivery.
The modern technique is based on stepping the probe along the longitudinal direction
from the gland base to apex (in 5 mm steps). The grid serves as a needle guidance
template, giving precise coordinates for the required positions of the needles and their
sides; ”by this procedure, each needle and seed can be accurately positioned in a 3D
coordinate system- exactly at the place determined in advance during the relevant
planning procedure” (6). An example of transverse images obtained via ultrasound
are shown in Figure 2.13.
Following the development of transrectal ultrasound (TRUS) and then computed to-
mography (CT) imaging, the precision of radioactive source placement and subse-
quent outcomes greatly improved. Throughout the 1990s, several institutions began
implant programs that used transperineal guidance as the preferred approach. Some
centres of note are the Memorial Sloan Kettering Cancer Centre, New York and the
Seattle Prostate Institute, Washington.
As time progressed, brachytherapy became the preferred choice of therapy for prostate
cancer over other choices such as EBRT and radical prostatectomy and has many
well-understood advantages. These are described by DiBiase et al. (24) as follows:
1. Low-energy radioactive sources (I-125, which is low dose rate or Pd-103,
which has a higher dose rate) have limited tissue penetration, which allows
for a steep dose gradient thereby limiting the dose received to normal tissues
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Figure 2.13 (Left) Transverse endorectal ultrasound image displaying the dimensions of the
prostate (width and thickness) as well as the urethra and the rectum. In addition, there is
evidence of gross tumour in the right posterior-lateral part of the prostate. (Right) The distri-
bution of I-125 in the ultrasound prostate volume study. The prostate, the PTV, the urethra,
and the rectum are delineated. The number of seeds in the volume and their topographic po-
sition within the 3D coordinate system can be precisely calculated, determined and displayed
in different orientations. Isodose lines are shown in relation to the PTV (V100). Certain dose
constraints for the urethra and rectum must be taken into account (6).
and minimising potential treatment-related complications;
2. Gland movement, which can significantly affect the accuracy of EBRT, is less
of a problem during implantation using real-time ultrasound imaging. It is a
well-known clinical problem that the prostate is a very mobile and malleable
organ, and real-time monitoring of the needle and seed insertion is of utmost
importance;
3. A single outpatient treatment is convenient and less time-consuming than EBRT,
which is typically administered over 7 weeks;
4. The precision and conformation of brachytherapy permits the administration
of high radiation doses with a low risk of rectal morbidity.
There is no debate that permanent prostate brachytherapy techniques are associated
with excellent biochemical outcomes. However, prostate edema and poor imaging
techniques are recognised limiting factors and new treatment planning techniques
may assist in improving the implant procedure and associated dosimetry (33).
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Over the past 20 years, physicians at the Seattle Prostate Institute have performed
more than 10,000 LDR I-125 implants with or without supplemental EBRT (7). Dur-
ing this time, the Seattle technique has undergone continuous evolution, but the tech-
nical improvements had not been published until 2009. Sylvester et al describe their
preplan technique and associated dosimetric outcomes. An example of error in im-
plant is shown in Figure 2.14.
”The literature has consistently shown that excellent biochemical relapse-free sur-
vival (BRFS) outcomes occur whenever postoperative CT dosimetry reveals a high
dose to 90% of the prostate and/or high volume of prostate receiving 100% of pre-
scription dose, with either preplanned or intraoperative planned techniques”. Dosime-
try techniques involve creating a preplan that is simple and easy to reproduce in the
operating room (OR) based on TRUS preplanning volume studies.
At the end of the procedure (post-operative), a fluoroscopic image for seed verifi-
cation purposes is taken, as is an ultrasound scan to identify potential cold areas.
”Some centres will excel at the preplan technique [like at Seattle] and others with the
real-time technique. Fortunately, with the aid of postoperative dosimetry feedback,
all brachytherapists should be able to maximise the quality of their implants” (7).
Lawton et al. (34) provide an historical perspective of prostate brachytherapy proce-
dures and evaluate the effectiveness of Holm’s TRUS-guided technique as compared
with historical data for both radical prostatectomy and EBRT. Overall in Lawton’s
study, it was found that multiple large series from single institutions have reported
favourable results from TRUS-guided implantation techniques and similarly so did
their multi-institutional series.
While the failure of the retropubic approach may have discouraged the use of prostate
brachytherapy, the development of transrectal ultrasound (with the ability to map the
prostate in several planes) technology as well as the associated development of the
perineal implantation technique of prostate seed implants revived clinical interest in
the concept of implantation of radioactive sources.
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Figure 2.14 A comparison of pre-planned TRUS images to the final seed position as the
implant procedure progresses (7).
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Figure 2.15 Flow diagram of basic steps involved in preplanning, interactive planning and
dynamic intraoperative planning (Zaider et al)
2.3 Treatment Planning
Precise seed ordering is traditionally facilitated by preplanning. The aim of such
planning is to ensure maximal target coverage while minimising dose to organs at
risk and taking into account internal dose inhomogeneities. However, there are a
number of fundamental issues to overcome, which are rigorously addressed in the
literature.
To address these issues, first a breakdown of the treatment procedure must be out-
lined. Zaider et al. (35) provide a flow diagram as shown in Figure 2.15.
The implantation step is performed to adhere to the treatment plan as close as possi-
ble. However, this is technically complex to attain to 100% accuracy, and therefore
adaptive replanning, such as through dynamic dose calculations, may be a preferred
method. Furthermore, it is also difficult to exactly replicate the patient’s position in
the operating room based on treatment simulation and preplanning. Prostate edema
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is another concern that may be addressed by intraoperative planning.
The primary reason it is important to obtain real-time dosimetric information during
the implantation procedure is to reduce the potential for toxicity without compro-
mising target coverage. Any need for intraoperative adjustments is eliminated by
adjusting the plan in real-time as in interactive and dynamic planning.
”Preimplant quality assurance covers seed and needle calibrations, re-
view of the dose calculation, plan verification...Broadly, intra-implant
quality control is concerned with monitoring and correcting any dis-
agreements between the wanted and achieved dosimetry.” (35)
While intraoperative dose planning is highly recommended, seed localisation re-
mains a key unsolved problem as dosimetry issues, both over- and under-dosing,
require careful tracking of seed positions ”as the implant progresses” (35).
2.3.1 Preplanning
The preferred method for brachytherapy implants is preplanning. In this method, an
ultrasound volumetric study is performed on the patient prior to the operation; usu-
ally 6-8 weeks before. Fundamental dosimetry information such as the number of
seeds required and the position of the seeds are planned according to the patient’s
specific prostate volume and tumour size. A computerised three-dimensional model
of the gland is generated and virtual placement of seeds performed with superim-
posed planar isodose curves.
In addition to ultrasound imaging, preplan CT techniques are also employed at some
centres such as Memorial Sloan- Kettering Cancer Center (MSKCC) in New York.
The CT scan is made several days to weeks before the procedure. Prostate, urethra
and rectum contours are outlined on 5 mm slices and digitised into the treatment
planning computer. Using these transverse images, seed patterns and isodose distri-
butions can be calculated for each cross-sectional image. Following evaluation of the
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isodose patterns, alterations in seed locations can be made to adjust dose distribution
of the target, urethra and rectum (8).
When seed implantation occurs in the operating theatre, the patient is positioned
in the same position in an attempt to exactly replicate the conditions in which the
preplan was designed. Studies have shown however, that it is an extreme technical
challenge to match the prostate to such preplans (36).
Following the implant, a quality check is performed by three-dimensional CT-based
analysis in all planning methods. Five-millimetre thick slices are acquired with both
soft tissue and bone windows, thus allowing for prostate and seed delineation. The
evaluation consists of dose computation and analysis for the target structure and sur-
rounding organs. Computer analysis is performed based on the CT scans to produce
accurate isodose level displays (32).
The preplanning method was popularised by the Seattle Northwest cancer group pi-
oneered by Holm et al. (5) at the Seattle Prostate Institute, and discussed in detail
by Ragde (37). It is sometimes referred to as the Seattle method. However, despite
success in past decades, there are several limitations associated with the preplanning
technique as outlined in the following.
Variability in prostate shape and position is unavoidable in the time period between
preplanning and implant. (38; 39). Changes are due to differences in patient po-
sitioning and relaxation of the pelvic musculature as a result of either regional or
general anaesthesia. Differences in the ultrasound probe position as well as distor-
tion of the prostate associated with needle placement and subsequent edema can also
result in profound changes in the shape of the gland compared to the preplanned pro-
static contour (40). These deviations result in a postplan CT dosimetry that does not
always correspond to the idealised preplan.
Furthermore, an underdosage may occur reflected in a lower V100 value and poten-
tially increased risk for local recurrence (8). Intraoperative planning as a conformal
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Figure 2.16 Target coverage for patients with prostates larger than 60 g according to the
treatment planning technique based on the postimplantation dosimetric analysis. It is evident
that significant improvement was observed for the IO-3D technique (8).
method takes the first step in addressing some of these issues.
Gewanter et al. (41) summarise the three main technical problems of the preplanned
approach as follows:
1. The need for matching of the images obtained in the preplanning study with
the actual implant images allows room for error in matching the images;
2. The prostate volume or shape may change as a result of any of the following-
hormone treatment, positioning factors, the ultrasound probe itself or relax-
ation of the pelvis due to anaesthesia;
3. This approach requires the scheduling of two separate ultrasound procedures,
which can be difficult as it depends on the availability of physicians, patients,
and ultrasound equipment.
Recent studies have shown that preplanned techniques continue to yield favourable
biochemical outcomes, yet there is also a growing movement towards intraoperative
Literature Review 36
Planning modality Description
Intraoperative planning Creation of a plan in the operating room immediately
prior to the implant. Emphasis on single-room execu-
tion of plan
Interactive planning Step-wise modification of the treatment plan based
on real-time dosimetric feedback derived from image-
based actual needle position
Dynamic dose calculation Continuous feedback of seed positions to perform up-
dating of calculations of dose distributions as they are
being implanted
Table 2.4
Some terminology used to describe different approaches for intraoperative treatment planning
for PPB.
adjustments as a way to develop a single-step procedure whereby the entire planning
and implantation process can occur in the same room (7; 40).
2.3.2 Intraoperative Planning
There are several different approaches to intraoperative planning, as outlined by Polo
et al. (42) and shown in Table 2.4.
The prostate is a highly mobile and malleable organ. Real-time monitoring of needle
and seed insertion is of utmost importance. Vital advances in computer treatment
planning and image guided treatment have made recent real-time dosimetry and im-
plantation possible.
There are two clinical interpretations of the term ’intraoperative (IO) planning’. Both
aim to minimise error introduced in preplanned treatments whereby the planned
prostate volume does not necessarily match the implanted volume. The aim is to
maintain the benefits of preplanning while eliminating the disadvantages of planning
errors by streamlining the two procedures into a single operative session.
The first step in IO planning is to bring all planning equipment and computerised
analysis directly into the operating room. In doing this, the prostate can be visualised
and all dosimetry calculation performed immediately prior to the implant process. At
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present, approximately 5-15% of seed implantations will not achieve optimal target
coverage, which is usually defined as V100 >90% and urethral dose <150% simul-
taneously. However, it is undeniably advantageous to identify inadequate implants in
the patient while he is still in the OR and in the treatment position (38).
The time elapsed between planning and implantation is minimised and therefore any
differences between the planning and implant stages can also be minimised since
the patient is stationary and the same position is maintained between planning and
treatment. This form of IO planning is essentially the same as preplanned treatment
apart from the time and place of planning. Once the plan is finalised, the needles are
inserted accordingly with little attention paid to any probable required adjustments.
The method of dynamic IO planning accounts for this; a method also known as in-
teractive planning. The ability to treat prostate cancer is limited by the ability to
visualise the organ and brachytherapy seeds as they are being inserted. Therefore,
the ideal situation would be an imaging system that provided not only anatomical
information during the implant, but also provided real-time dosimetric feedback as
per seed location and associated radiation levels.
Surgeons mainly rely on the TRUS probe to image the prostate in real-time as the
needles are inserted and the seeds deployed. The needle tips register as bright echo
spots on the ultrasound display, but due to resolution limits inherent in ultrasound
technology individual seeds are easily missed in the same image. Therefore, X-ray
fluoroscopy is also used to assist the surgeon in determining seed position. It is
widely acknowledged that seed localisation is the most significant issue in achieving
optimal dose distribution across the tumour. Currently this issue is being resolved by
ever-improving ultrasound techniques and sophisticated treatment planning software
for dosimetric calculations, capable of quickly determining seed number, activities
and seed locations for optimal coverage of the target volume (36).
Well-documented inaccuracies in seed placement means that carrying out a plan re-
sults in a large degree of variability relative to the intended dose distribution (43).
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Suboptimal seed implant leads to poor patient outcome, in the form of either lo-
cal recurrence or radiation toxicity of critical structures. Unforeseen difficulties can
be overcome in real-time with intraoperative adjustments. These modifications can
potentially correct any areas of tumour underdosage prior to completion of the pro-
cedure, and thus have become known as interactive dose planning.
”The interactive implant technique allows real-time prostate measure-
ments, and bases its dosimetry calculations on the actual gland volume
and configuration at the time of implant, thus intrinsically correcting
for gland movement and dynamic size changes occurring during the
operation. The technique does not require extensive, expensive time-
consuming preplanning.” (36)
Currently however, the majority of centres and techniques do not incorporate com-
putational tools that allow for real-time adjustment of overall dosimetry as a result
of seed movement, needle distortion and edema during the implantation process as
there is still much to be done in developing real-time dosimetry and its ability to
predict for good quality implants.
In the study performed by Matzkin et al. (36), it was found that short-term morbidity
was minimal in both groups and did not in fact correlate with technique employed.
However, when further dosimetric parameters (such as V100, V150, D90 of prostate
and urethra) were considered it was found that the real-time intraoperative method
achieved superior dose distribution and homogeneity. Note that V100, V150 is the
percentage of volume receiving 100% and 150% of the prescribed dose respectively.
D90 is the dose that covers 90% of the prostate volume. It is usually reported in
grays [Gy], but can also be reported as a percentage of the prescription dose. They
are common parameters used to evaluate the quality of the brachytherapy implant
and are further explained in Section 2.4.
”The interactive implant technique allows real-time prostate measure-
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ments, and bases its dosimetry calculations on the actual gland volume
and configuration at the time of implant, thus intrinsically correcting for
gland movement and dynamic size changes occurring during the opera-
tion”.
Current advances in imaging and computing technology have allowed for the devel-
opment of real-time intraoperative dosimetry. The recommendations made by Nag
below have been taken on board and practically applied in many clinical contexts
worldwide as evidenced in the literature.
”The high degree of accuracy achievable in prostate implants nowadays
is partly due to technological improvements, but quality implants still
require skill, adequate training and attention to detail. The ABS suggests
development of real-time, online dosimetry to allow immediate feedback
that could result in better implant dosimetry”. (23)
Real-time intraoperative planning also has its limitations according to Shanahan et al.
(44). The main issue to address is the limitation in ultrasound technology, which
has intrinsically low seed visibility. For this reason, the needle tip at the time of
deployment tends to be imaged rather than the final resting position of the seed itself
within the gland.
Seed migration is a typical problem and is not easily detected without conventional
fluoroscopy. However, it is concluded that the interactive planning consistently re-
duced preplanning time, procedure time, and number of needles used, thus reducing
treatment time and costs while maintaining excellent dosimetric coverage (day 0
dosimetry reported D90>140 Gy, V100>90%, and V150<40%).
Whether a preoperative plan or an intraoperative treatment plan is used, ultrasound
guidance is vital for a successful implant. Visualisation of the prostate and other
critical structures is needed for the setup. Ability to localise the inserted seed, some-
times assisted by additional imaging techniques such as fluoroscopy, is necessary for
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modification of the preplan and for real-time planning. Such approaches will further
improve the quality of the dose distributions and the therapeutic ratio for permanent
prostate implants (45).
Planning and assessment methods vary from centre to centre, but generally current
techniques do not incorporate or allow for intraoperative reassessment (43).
To illustrate the need for a real-time dosimetric feedback system, several studies have
been performed across the world using novel imaging techniques. One example is
by French et al. (9), who developed a system able to accurately locate seeds with
minimal impact on the then current protocol for prostate brachytherapy. In their
study, fluoroscopic C-arm images are used in conjunction with conventional ultra-
sound. Conventional X-ray based methods, such as those used by Gong et al. (46)
and Todor et al. (47), depend on the rotation of the C-arm fluoroscope to compute
the seed distribution, which is a time-consuming and impractical method.
It is acknowledged in such studies that is it is ”not possible for a radiation oncologist
to accurately locate the implanted seeds using [either] only TRUS or fluoroscopy
[alone]”. Several existing commercial systems have already been developed that rely
primarily on ultrasound imaging to compute dosimetry based on such information as
needle location. However, there are incorrect assumptions inherently made in these
calculations and seeds simply cannot be located using only US images. Such systems
include:
1. VariSeed by Varian Medical Systems, Palo Alto, CA
2. Prostate Implant Planning Engine for RT systems by RTek, Pittsford, NY
3. Interplant Suse by Rosses Medical Systems, Columbia, MD
4. SPOT system by Nucletron Corporation, Neenandaal, Netherlands
The aim of the French study was to obtain X-ray images of the TRUS probe in-body
Alternatively, French et al designed a procedure based on needle path interpolation,
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Figure 2.17 (a) Illustration of the standard TRUS probe with needles being inserted into the
prostate and the coordinate system used in this study; (b) Fluoroscopic image of the phantom
with TRUS probe and needle inserted (9).
which importantly required no additional equipment and had minimal change to the
existing brachytherapy procedure. The transformation from the fluoroscopic image
to the TRUS image is defined using a single fluoroscopic image of the TRUS probe
such that the seed coordinates can be projected from the fluoroscopic images to the
TRUS images (X,Z coordinates) (an example image is shown in Figure 2.17).
This demonstrates an early example of an attempt at real-time dosimetric feedback.
However, to date, there is no robust system in widespread use for intraoperative treat-
ment planning. Further examples are highlighted in Section 2.5.
2.4 Dosimetry
In order to evaluate the effectiveness of a given implantation procedure, a freedom
from biochemical failure is determined. Failure is defined as a rise in PSA of 2
ng/mL and it is well known that treatment success is closely associated with the
dosimetric quality of the implant (48). The American College of Radiology (ACR)
and the American Society of Therapeutic Radiology and Oncology (ASTRO) pub-
lished an educational tool written to assist brachytherapy practitioners (49). It is
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Figure 2.18 (a) Flowchart outlining French et als approach for real-time dosimetry feedback
(9).
noted that dosimetric planning should be performed on all patients prior to or during
the umplantation with methods listed such as TRUS, CT scanning or MRI. For dose
calculations, the AAPM Task Group No.42 and its successors should be adopted.
Typical post-implant dosimetry sometimes reveals that a portion of the prostate has
been underdosed. There is no method for successfully integrating intraoperative
imaging into the dosimetric assessment process. According to Doyle et al. (48), in-
traoperative planning allows more flexibility in all key areas affecting brachytherapy
efficacy. i.e. patient position, seed localisation and of course real-time dosimetry and
supplemental seed implantsation. Such freedom for the brachytherapy practitioner
allows the minimisation of deviations from ”intended seed location and dosimetry”.
2.4.1 Quality Assurance
The goal for any prostate brachytherapist ”is to consistently achieve high-quality im-
plantation results, as determined by postimplant dosimetry.” (50). In order to ensure
that source placement is optimised to maximise target coverage while minimising
dose to the organs at risk (in this case, primarily the urethra and the rectal wall),
Literature Review 43
the standard post-implant dosimetry check must be performed. For the past decade,
post-implant CT-based dosimetry has become the foremost and most reliable method
for assessing dose delivered to the prostate and normal surrounding structures (51).
This method involves taking CT scans of the brachytherapy implant, with the prostate
contoured on every 3-5 mm slice. Seed locations are identified on every CT slice,
and all relevant structures reconstructed in three dimensions with dose distributions
calculated. The timing of the post-implant dosimetry is recommended at one month
after implant, since ”the dose calculated at one month has been shown to most accu-
rately represent the delivered dose over the life of the implant” (51). This is due to
swelling and edema of the prostate gland associated with the physical trauma of the
implant.
However, it is common for significant differences to exist between the optimised
US-based treament plan and the actual post-implant dosimetry check performed. In
a study by Ishiyama et al. (39), the results between intraoperative ultrasound-based
dosimetry and CT-based post-implant dosimetry scans performed one day and thirty
days after implant, showed significant differences in dosimetric parameters. Some
centres such as the University of Texas M.D. Anderson Cancer Center (Houston,
Texas) have employed a hybrid system, combining the basis of preoperative imaging
with modern treatment planning software for use as intraoperative optimisation (50).
”Postimplant dosimetry is mandatory for each patient. This information
expresses the actual dose delivered and identifies variance from the orig-
inal treatment plan. Although useful for seed counting, plain radiographs
alone are not adequate for dosimetric analysis. We recommend the use
of image-based planning such as CT or MRI to evaluate the relationship
of the seeds and the prostate, bladder and rectum”. (49)
There is some debate surrounding the optimal timing for post-implant CT and/or
MRI. Recent studies have suggested somewhere between 2-6 weeks post-implant,
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Figure 2.19 Transverse CT image of implanted prostate: (a) without contoured prostate; (b)
with prostate contoured (Stock et al, 2002)
allowing any edema to subside, whilst in other situations, post-implant scans are
performed at day 0 or day 1 after implantation.
The typical values reported in a useful dosimetric analysis are outlined by the Amer-
ican Brachytherapy Society (23):
1. The prescribed (intended) dose;
2. The D100 value - i.e. the dose that cover 100% of the prostate volume. How-
ever, there is some uncertainty associated with delineation of the prostate bound-
aries in CT scans;
3. The D90 value - i.e. the dose that covers 90% of the prostate volume. A D90
value greater than or equal to the prescribed dose is a measure of a implant
quality;
4. The V100 - i.e. the percentage of prostate volume that received the prescribed
dose. If the dosimetry indicates significant underdosage, a reimplantation or
additional EBRT may be considered.
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2.5 Current Methods for Real-Time Seed Imaging
Several attempts have been made at accommodating this need for a real-time imag-
ing system in permanent prostate brachytherapy. Approaches vary from modifying
existing technology to innovations in imaging and treatment planning applications.
2.5.1 Ultrasound Technology
Ultrasound imaging plays an integral part in the brachytherapy procedure. The TRUS
probe (discussed in Section 2.2.2) is a standard in clinical practice and is able to
visualise the implant as it occurs. By attaching the probe to a stepper apparatus,
in turn attached rigidly to the patient bench, a stable and well-defined coordinate
reference system can be established. However, due to the intrinsic resolution limits
of ultrasound technology, it is not uncommon for seeds to be misaligned or only
approximated regarding their expected positions.
Ultrasound’s main advantage is in imaging soft tissue anatomy. However, it is well
known to have disadvantages for localising the exact location of the small brachyther-
apy seeds. Several studies have been made into changing the design of the seeds
themselves so as to better reflect the ultrasound waves and thus have increased visi-
bility in ultrasound scans (52; 53; 54).
While there are some disadvantages in using ultrasound imaging for real-time seed
imaging, it remains the standard for real-time imaging for its ease of use and its
established history as a useful and reliable anatomical imaging device.
2.5.2 Fluoroscopy
During the implant procedure an X-ray radiograph of fluoroscopy image is taken
to further verify the positions of the implanted brachytherapy sources. As discussed
above, ultrasound imaging alone is not capable of localising implanted brachytherapy
sources.
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A common approach to this problem is to take several radiograph images and to
co-register the multiple views onto a common frame of reference and thus obtain a
three-dimensional map of the seeds in their implanted positions. There is a common
problem however of missed seeds.
An example of this is the REDMAPS algorithm, which stands for the reduced di-
mensionatliy matching for prostate brachytherapy seed reconstruction (55).
In this method, The seed localisation problem from multiple fluoroscopy images is
modelled as an assignment problem. This approach resolves segmented seeds in
each projection image, assigning them to the same physical seed. The 3D locations
of the seeds are determined by computing the intersection of the lines connecting the
segmented seeds to the x-ray source positions based on the revealed seed correspon-
dence. This is a seed assignment and geometric solution.
2.5.3 CT Imaging
CT scans are a crucial part of the brachytherapy procedure as a post-implant dosime-
try check, as discussed in Section 2.4.1. Ultrasound imaging is poor at seed localisa-
tion. CT scans are perfectly suited to imaging of the high contrast material implanted
into the prostate. Some studies have been conducted in placing the patient in the
lithotomy position within a conventional CT scanner for the utilisation of real-time
CT imaging of the implant as it occurs.
Whilst this may be a viable option for accuracy of seed localisation, it is not a cost-
effective nor is it an easily accessible solution to the question of real-time seed imag-
ing.
Because the quality of the procedure is only evaluated using postim-
plantation computed tomography (CT), less than optimal dosimetric out-
comes only become apparent to a physician when reviewing the postim-
plantation CT scans; thus, making amends for a flawed implant requires
an additional surgical procedure
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Figure 2.20 Patient shown with implanted needles in extended lithotomy position with CBCT
imager in place as presented by Zelefsky et al (2010)
In a study by Zelefsky et al. (56), a technique using a mobile fluoroscopy-CBCT
(cone beam CT) unit (O-arm, Medtronic Navigation), which uses an X-ray source
and a Varian flat panel detector for both stationary fluoroscopy/radiography and
CBCT imaging was evaluated. The central aim of this study was to establish the
feasibility of fusing seed coordinates from the intraoperative CBCT images with that
of the intraoperative ultrasound images. The technique was confirmed successful
for use in fusing the seed coordinate positions obtained from the CBCT scans with
the ultrasound frame of reference ”to allow for potential corrections of suboptimal
dosimetry while the patient remains anesthetized”. A photo of the set-up is shown in
Figure 2.20.
Other studies involving intraoperative CT imaging looked at the end of the implant
procedure to compare its accuracy with that of standard postimplant CT scans, or
to use it as a tool to correct subopimtal areas of dpse. For example, a study by
Westendorp et al. (57) demonstrated the feasibility of a C-arm CT method. However,
due to the nature of the C-arm configuration, the patients couldnot be imaged in the
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extended lithotomy position, and scans were performed without the TRUS probe in
place, which neglects the deformations introduced in the prostate.
Furthermore, in another study by Steggerda and van der Poel (58), 3D TRUS scans
were successfully fused with standard CT scans. Again, most patients cannot be
scanned in the standard lithotomy position in conventional CT scanners. Further-
more, Zelefsky states:
”One of the prominent limitations of current brachytherapy techniques
precluding intraoperative quality assurance assessment is related to the
relatively poor ultrasound resolution of the individual implanted seed
coordinates. This primarily results from intraoperative prostatic edema,
hemorrhage secondary to needle placement, and the relatively poor res-
olution of ultrasound images...The advantages of accurate intraoperative
assessment of implant adequacy compared with the standard approaches
that rely on postoperative measurements are obvious. Not only would
such approaches obviate the need for post-implantation CT scan assess-
ments, but more importantly, they would provide an opportunity for cor-
rections or refinements of the implant before the procedure has been
completed” (56).
2.6 Timepix Detectors
Although originally developed for the detection of high-energy ionising particles and
radiation, semiconductor pixel detectors have found many applications in a wide
number of areas, as diverse as radiation protection and in the photographic cameras
of every day life.
The Timepix detector is the latest generation of the Medipix detector, which was
developed by the Medipix collaboration at CERN (59; 60). The Medipix was orig-
inally proposed as a noise-free imaging solution for particle tracking in 1995. The
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earliest version of the Medipix consisted of 64×64 pixels. Three subsequent genera-
tions later, and the ability for spectroscopic imaging and particle track identification,
has propelled the Medipix collaboration to the forefront of pixellated semiconductor
imaging devices.
The Medipix is a pixellated, hybrid semiconductor detector, consisting of 256x256
pixels, of 55µm pitch. The sensor layer is typically made of silicon, as shown in
Figure 2.22. Each pixel is bonded to a supporting chip with separate read-outs. It
has applications in high energy physics particle tracking as well as some imaging
purposes, mostly in entomological and botanical (plant seed) studies (10).
The Medipix2 was developed towards the end of the 1990s. It consists of a high
spatial, high contrast resolving CMOS pixel read-out chip working in single pho-
ton counting mode. It can be combined with different semiconductor sensors which
convert the X-rays into electric signals. The incoming ionising radiation generates
charge within the sensor layer, which is collected at the readout chip. The voltage
is compared to a set threshold in the readout electronics. This threshold can be cali-
brated to a known isotope energy. Every photon that passes the sensor material within
a defined energy range can therefore be measured as single events. This presents a
new solution for various X-ray and gamma-ray imaging applications. The principle
of operation is shown in Figure 2.21.
2.6.1 Properties of Timepix
The Timepix chip evolved from the development of the Medipix2 detector. The pix-
els have identical size to those of Medipix2 but with increased functionality. Every
Timepix pixel can be programmed to count single events like Medipix2. However,
the Timepix has the added functionality of comparing the voltage pulse generated to
an internal clock, providing spectroscopic information of the incoming radiation. The
voltage height is directly proportional to photon energy. As it peaks over the thresh-
old setting and decays away, the time over the threshold can be directly calibrated to
energy in keV. This is known as ToT or Time-Over-Threshold measurements.
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Figure 2.21 Schematic showing principle of Medipix detector operation. Ionising radiation
impinges on the sensor layer and generates charge. This charge is collected in the readout
electronics which is converted to an analog signal. This signal is compared to a threshold
level (THL). Events above the threshold are registered as counts.
One of the advantages of the Timepix is that an appropriate sensor can be chosen
such that the device can be used for registration of virtually any type of ionising
radiation. The most common design makes use of 300 µm Si, but other materials
such as GaAs or CdTe are also available. Each pixel in the matrix is connected to its
respective preamplifier, double discriminator, and digital counter integrated on the
readout chip. The Timepix detector is the focus of the majority of this thesis. The
Timepix was designed as a successor to the Medipix2, the main difference being in
the read-out chip (60).
Each pixel can be configured to work in one of three modes:
1. Medipix mode: integrated counter works as an event-by-event counter;
2. Timepix mode: counter works as a timer and measures when the particle is
detected;
3. Time Over Threshold mode: or ToT mode. The time that the input voltage
remains above the set threshold corresponds proportionally to the energy of
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Figure 2.22 Photo of a single Timepix connected to FITPix USB interface.
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Figure 2.23 The hybrid semiconductor device Timepix consists of two chips: The pixellated
sensor chip (usually 300 µm thick silicon, but also other materials are available e.g. GaAs
and CdTe) and the read-out chip (10).
Figure 2.24 Schematic of a Medipix. Image courtesy of CERN.
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the detected particle, thus allowing a direct measurement of particle energy.
This is known as a Wilkinson-type analog-to-digital converter (ADC).
2.6.2 Comparison with Other Detectors
The typical procedure in radiation imaging involves a beam of radiation traversing
the object you wish to image and obtaining a transmission image as the beam is
modified through the object, i.e. attenuated to have its intensity, beam composition,
energy spectrum modified. The recorded images correspond to the internal structure
of the investigated specimen. The quality of the irradiating beam combined with
the performance of the chosen detector determines the quality of the resulting radio-
graph.
Currently, the three main techniques for radiation imaging are:
1. Film chemical emulsions - largely unsuitable for modern diagnostic systems
due to their limited dynamic range, non-linear response and absence of real-
time digital output. Considered largely obsolete;
2. Charge integrating devices such as flat panels, CCD or CMOS sensors pro-
vide good spatial resolution for a low cost, but also have limitations in limited
dynamic range, limited linearity, integration of noise and ’dark current’ issues;
3. Single-particle counting pixel detectors contain separate electronics and digi-
tal counter for each pixel, such that every particle is processed independently
(signal amplification, discrimination and counting). The digital counter incre-
ments without any dark current and full suppression of electronic noise such
that the result is absolutely linear and dynamic range virtually unlimited.
One such semiconductor hybrid device in the category of single-particle counting
pixel device is the Medipix (and therefore the Timepix). The typical hybrid detector
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is composed of two chips. The sensor chip is a semiconductor diode with one back-
side and pixellated contact. The second chip contains the read-out electronics for all
pixels. The chips are connected by bump-bonding technique.
Lastly, due to its high resolution, lack of noise and practically unlimited dynamic
range, the Medipix detector has many applications in high-contrast X-ray transmis-
sion radiography of soft tissue and other industrial and ecological materials. It is also
highly sensitive to low energy X-rays, and therefore perfectly suited for high contrast
X-ray attenuation/transmission imaging in biological samples. Besides some prelim-
inary application in ocular brachytherapy QA (61), there have been no real medical
applications of the Medipix. Some applications have been found in mixed radiation
field dosimetric work (62).
2.6.2.1 Use of Timepix in Dosimetry
These properties of Timepix make it perfectly suited for use in particle tracking, and
in personal dosimetry applications. However, to date, there has been no specific
medical application of the device.
For example, the Timepix has been successfully used in radiography, neutronography
and micro-CT. In a study performed for ocular radiotherapy QA by Weaver et al. (61),
it is established that the Medipix operating in a spectroscopic mode is able to generate
high-resolution dosimetric maps when placed below the treatment plaque within an
eye phantom. Other applications include detection of neutrons at the ATLAS detector
(CERN), and space dosimetry on the International Space System (62).
The following reasons justified our use of Timepix for application in BrachyView:
• Small physical size
• Real-time read-out
• High spatial resolution
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Figure 2.25 An example of a table-top mouse pinhole imaging system using an I-125 scan
of a mouse thyroid (11).
2.7 Pinholes in Brachytherapy
The use of pinholes in radiation therapy is typically limited to applications in ra-
dionuclide imaging, SPECT imaging or as coded apertures. Pinhole gamma camera
imaging offers the ability to obtain high-resolution images of gamma-emitting trac-
ers in small objects such as that discussed in a study on I-125 imaging in mice by
Beekman et al. (11). The excellent imaging characteristics of the pinhole lends its
use to imaging the human thyroid and small animals.
In clinical radionuclide imaging, the pinhole serves as a collimator for gamma rays
and has been used mainly for the imaging of small volumes such as the thyroid.
Multi-pinhole imaging has also been used to image relatively small organs such as
the thyroid, shoulder, hip, neck ad heart, but to date, it has not yet achieved broad
clinical application (14). An example of a small mouse organ imaging application is
shown in Figure 2.25.
2.7.1 Gamma Camera Mode
In brachytherapy, some studies have pursued the application of pinhole imaging for
the localisation of implanted sources. However, none, to the author’s knowledge,
have proposed an application as an in-body imaging device and therefore as an intra-
operative real-time imaging system and dynamic dose optimisation planning system.
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Figure 2.26 (Left) Schematic of pinhole design in tungsten collimator. (Right) Diagram il-
lustrating two straight lines l1 and l2 connecting the images of the HDR source I1 and I2 to
their respective pinholes H1 and H2 that produced the image, and their common perpendic-
ular line l (12).
By using the implanted seeds themselves as the source of imaging radiation, the
camera obscura concept lends itself perfectly to the application of real-time seed
localisation in prostate brachytherapy. As the seeds emit their therapeutic dose, some
percentage of the radiation can be transmitted to the BrachyView probe through the
pinholes.
Duan et al. (12) used a tungsten collimator combined with a film screen for HDR
seed localisation. This study proved that ”the pinhole imaging method is capable
of providing independent and reliable real-time monitoring and verification of HDR
brachytherapy”.
2.7.2 Pinhole Design
Pinhole imaging with gamma rays is based on the same geometric principle as the
optical pinhole camera, where the lenses in an optical system have been replaced
by the pinhole. Several fundamental factors must be considered when employing
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pinhole systems. Such factors include the system sensitivity, spatial resolution and
the field of view.
As discussed by Beekman et al. (11), the decrease in quality of pinhole images is a
result of the decrease in count sensitivity S with increasing distance z between the
emitting source and pinhole. For a point source located in the centre of the field of
view, S ≈ D2/16z2 where D is the hole diameter.
Now consider the resolution of the pinhole system. This is dependent on geometric
factors and the intrinsic resolution of the detector as well. The geometric resolution
is:
Rg ≈ D(l + z)/l
where D is the diameter of the pinhole, l is the distance between the pinhole and the
detector, and z is the distance between the source and the pinhole.
However, taking into consideration the intrinsic resolution Ri of the detector system
and assuming a Gaussian-shaped kernel for pinhole blurring, the total resolution is
given by:
Rt ≈
√
[( z
l
Ri)2 +R2g]
This has the effect of reducing the overall resolution.
All these factors were taken into account in the preliminary design of BrachyView.
The pinhole design must be such as to cover the entire region of interest, i.e. the
entirety of the prostate gland. When considering the high resolution of the Medipix
device, the application in gamma camera imaging for brachytherapy procedures is
suitable.
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2.8 Summary & Conclusion
The traditional approach of ultrasound-based preplanning in PPB has recently been
challenged by a rising group of intraoperative planning-based systems. The primary
goal of such an approach is to reduce the time gap between planning and implanta-
tion, and also to introduce the ability for adaptive replanning as the implant occurs
in order to account for any discrepancy between the planned prostate volume and
implanted volume.
Some centres have evaluated the use of CBCT and fluoroscopy imaging to achieve
this goal. However, to date no system is robust or economic enough for widespread
application. BrachyView has been proposed as such a system, utilising pinholes and
novel pixellated detectors in the form of the Timepix device for the development
of a novel in-body imaging system capable of preplanning volumetry, intraoperative
planning, and post-implant dosimetry in a single procedure in permanent implant
brachytherapy for prostate cancer treatment. The development of BrachyView ad-
dresses all the issues presented in the literature review, and presents a novel solution
to maximising patient outcome in the treatment of low to intermediate-risk prostate
cancer.
Chapter 3
Design
3.1 BrachyView Probe
The BrachyView rectal probe design is based on a multi-pinhole lead collimator and
tiled Medipix2/Timepix detectors with a geometry configured to fit inside the TRUS
probe (note that the average rectal cavity diameter is approximately 25 mm). Pre-
liminary experiments were based on a triple detector design, with later generations
focusing on a gapless quad chip design (63). The first prototype of such a design is
shown in Figure 3.3.
For the triple chip design, a total imaging area of 14×42 mm2 was available as an
array of 256×768 pixels, each with a pitch of 55×55 µm2. For our purposes of
experimental verification of the proposed brachytherapy seed position reconstruction
method, three pinholes were used to cover the entire field of view of the prostate
gland; i.e. each individual pinhole corresponding to one single detector. Future work
will also investigate the use of several pinholes in a modified form of a coded aperture
for example.
The first version of the quad detector design as shown in Figure 3.3 aims to overcome
the mechanical shortcomings of the triple design. i.e. by removing the gaps between
each detector. In detail, each Timepix detector requires wire bonds for data read-
out to the FITPix and to the Pixelman software. These run along the bottom edge
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of each detector in the triple configuration. By rotating each detector 90◦, the wire
bonds run parallel to the longitudinal axis of the supporting PCB and substrate. By
using edgeless Si sensor chips, a total area of 256×1024 pixels (corresponding to
14×56mm2) is achieved.
This work was made possible by the novel detector designs made in-house (at IEAP),
and later made available through an external spin-off detector company Advacam.
As of mid-2015, products such as the Widepix 1×5 detector array (14×70mm) were
made commercially available. Images of this device are shown in Figure 3.4.
When combined with the pinhole collimator, the brachytherapy sources themselves
act as the source of imaging radiation passing through the pinhole, casting their pro-
jections onto the detector plane. However, in contrast to traditional pinhole gamma
camera systems, BrachyView is based on a demagnification factor since the imaging
plane is smaller than the object being imaged.
This is made possible because of the unique spatial resolution capabilities of the
Timepix detector. As discussed in the previous chapter, each pixel has its own inde-
pendent pre-amplification channel and two signal discriminator levels. Each incident
photon deposits energy in its corresponding pixel, and the energy deposition is com-
pared to the threshold and the corresponding counter increases by one. This signal is
then read out digitally by a USB interface with a refresh rate of a few hundred Hz.
The resulting matrix of counts is a projection image of the seed on the imaging plane.
With a number of distinct projections of the same seed through a number of pinholes,
a three-dimensional coordinate relative to the probe/pinhole system can be obtained
using a back-projection triangulation method. As mentioned above, the number of
pinholes chosen was kept to the minimum required, such that one detector corre-
sponds to one detector. This was to simplify the feasibility study. The shape of
the pinhole and other geometric parameters were optimised to maximise the field of
view for the prostate size (typically with diameter around 40 mm). This method is
explained in full detail in Chapter 5.
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Figure 3.1 Triple chip design and the final product assembled with a 7 mm gap between each
active sensor chip.
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Figure 3.2 Prototype for triple chip design assembled with a 7 mm gap between each active
sensor chip.
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Figure 3.3 Quad chip showing gapless design mounted on an Al base (for cooling).
Figure 3.4 Example of Widepix 1×5 showing a 1×5 detector array. (13)
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Figure 3.5 Conceptual schematic of BrachyView concept showing prostate as a grey sphere
and triple detector with pinhole concept.
The concept schematic for the BrachyView probe is shown in Figure 3.5.
In this BrachyView design the diameter of the probe has to be suitable for use in-
vivo in the patient’s rectum, and has an outer limit of approximately 25 mm. The
ultrasound hardware has not been included in Figure 3.5. The final BrachyView
probe design is proposed to consist of two components:
1. The ultrasound hardware;
2. Timepix hardware and associated electronics, as well as a necessary cooling
system, since each chip consumes approximately 1 W of power. A multiple
chip assembly would have non-negligible heating effects.
Therefore, a rotational hardware system must be considered where an image acqui-
sition can be completed using ultrasound and then the alternate modality (i.e. the
Timepix) rotated around to the top, thus allowing several imaging modalities to be
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performed with the one device. To date, some twister-ultrasound apparatus designs
have already been designed, which incorporate such rotational motion. The rotational
system will consist of an interior shell system, so as not to introduce any motion
against the patient’s rectal wall. This is a reverse-engineering problem, and beyond
the scope of the purposes of this dissertation.
Chapter 4
Simulation Studies
In this chapter, two main simulation studies are presented. This simulation work
was used to justify the choice of pinhole design for imaging the prostate volume.
Firstly, analytic methods in MATLAB were used to quantify imaging capabilities as
a function of pinhole collimator parameters. Following this, a study into the pinhole
geometry using Monte Carlo method was performed. This involved the simulation
of a single LDR seed, as well as multiple seeds implanted into a volume of water
designed to simulate the prostate. From these results, a choice of lead pinhole colli-
mator was made for experimental, in-phantom studies.
4.1 Study of Background Noise of BrachyView
A radioactive point source was modelled in a three-dimensional coordinate system
in MATLAB (V2013b, license: Czech Technical University in Prague). The point
source was positioned in a cube of water modelling the prostate volume. As the inci-
dent photons travel through the water volume, they are attenuated according to their
primary energy. Assuming an apparent activity of 0.4 mCi (equivalent to 1.48 x 1010
decays per second), the expected number of counts per second at the detector plane
can be calculated based on the amount of attenuation through water and absorption
at the collimator.
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Figure 4.1 Schematic showing geometrical parameters used to evaluate background from
attenuation through collimator. Image not to scale.
The probability of photon absorption in the collimator is high because of the high
atomic number of lead and the low energy of the photons. However, depending on
geometric factors, a proportion may also penetrate through, generating some amount
of background events on the detector surface. An analytic model of the detector-
collimator-source system was developed in MATLAB. An evaluation of the signal
to noise ratio (background noise) was investigated in MATLAB as a function of
collimator thickness to model distance from the pinhole and pinhole parameters.
The geometric factors affecting the background noise include distance of the point
source from the collimator, collimator thickness, and pinhole size. These are shown
in the schematic in Figure 4.1 and summarised by:
Background −→ f(x, y, t, h, θ, d, z) (4.1)
where x and y represent the position of the source in one plane, t is the thickness of
the collimator, h is the vertical distance from the detector surface to the collimator, θ
is the aperture opening, d is the diameter of the pinhole, and z is the vertical distance
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Material µ (mm−1) ρ (g/cm3)
Lead 49.152 11.3
Water 0.11723 1
Air (35C) 0.000627 1.15E-3
Table 4.1
Linear attenuation coefficient values used to calculate penetration and background noise
through varying thickness of collimator. Values are shown for photon energy 27 keV
.
of the source from the collimator surface.
The values used to calculate attenuation are given by NIST standards (NIST). For a
Nucletron Model 6711 I-125 source, the linear attenuation coefficients corresponding
to the average energy of 27 keV was used, as shown in Table 4.1. Note that the linear
attenuation factor for air is taken at a temperature hotter than room temperature,
accounting for the in-body nature of the BrachyView system.
The signal to noise ratio can be calculated as the ratio between the photons passing
through the pinhole and those passing through the lead. This can be studied as a
function of the geometric factors (see Equation 4.1).
The coordinate system modelled in MATLAB is shown in the sketch in Figure 4.2.
Considering rays drawn from the point source, denoted by S, and each individual
pixel coordinate as denoted by point P, the angle between the vectors PS and OP (the
perpendicular joining S and the pixel directly below P) can be calculated. Assuming
that point source S is isotropic, this angle is key in calculating the expected length of
travel for each ray through each respective medium.
The photons travel through three regions before being detected. These are:
• Water volume;
• Collimator volume;
• Air volume.
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Figure 4.2 3D schematic showing geometrical parameters used to evaluate background from
attenuation through collimator. rx,ry,rz are the coordinates of the source in 3D. Image not to
scale.
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By defining the materials in the set-up as water (to approximate soft tissue), lead, and
finally air, the following values can be calculated for the length of material traversed:
Lwater =
rz
sin(θ)
(4.2)
Lcollimator =
t
sin(θ)
(4.3)
Lair =
h
sin(θ)
(4.4)
where rz is the perpendicular distance of S from the collimator, t is the thickness
of the collimator, θ is the angle between the vectors PS and OP (as shown in Figure
4.2, and h is the distance from the collimator to the detector (also see Figure 4.1).
Several physical limits must be considered: the diameter of the TRUS probe 23 mm,
and the size of the Timepix detectors 14 x 14 mm2 (see Figure 3.5 for a conceptual
image). Therefore, h is defined as 6 mm, allowing a maximal field of view for a
typical prostate volume. This is discussed in more detail with respect to pinhole
geometry in Chapter 5.
These lengths are then used in combination with the linear attenuation coefficient for
each respective material. The final intensity at the detector is then calculated based
on an initial activity of 0.4 mCi (typical of a fresh LDR seed). Attenuation through
the material can be calculated:
I = Ioe
(−µ·r) (4.5)
where Io is the initial source intensity at point S, I is the new intensity after traversing
through a medium of length L, µ is the linear attenuation factor evaluated at the
average energy of I-125, taken at 27 keV.
Simulation Studies 71
Lastly, following the calculation of intensity at detector surface based on length of
ray traveled, a final factor has to be taken into account. This is the detection efficiency
of silicon for photon energy range coming from a typical I-125 source. Assuming
an average photon energy of 27 keV, silicon has a detection efficiency of 60% (NIST
value).
This model allows the calculation of expected count rates per second at the detector
surface. By varying geometric parameters such as collimator thickness and pinhole
diameter, a design for an experimental lead collimator can therefore be optimised.
4.2 Pinhole Geometry Optimisation
Using the method explained in Section 4.1, a distribution of counts can be obtained
through the single pinhole, and an evaluation of possible transmission events through
the collimator can be performed.
The point source S is placed 10 mm above the pinhole location, and the thickness of
the lead collimator varied between 100 µm and 300 µm. The pinhole is treated as a
point as the main aim of this investigation is to obtain an analytic model of counts at
detector surface, without taking into consideration the projection image shape (this
is later studied in Section 4.3).
The resulting images are shown in Figure 4.3.
In each plot shown in Figure 4.3, a map of the background counts (photons penetrat-
ing through the collimator) detected in the silicon sensor is shown on the left. The
background counts superimposed with the number of signal counts as a function of
increasing collimator thickness is shown on the right. Since the number of counts
through the pinhole is higher than the background by several orders of magnitude,
the superimposed image appears as a single bright spot. The actual number of counts
can be seen in the scale on the right of each image.
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By considering the central row of the modelled Timepix detector, a profile plot can be
obtained for each case calculated as shown in Figure 4.4. This allows an evaluation of
the photons passing directly through the collimator relative to the background noise.
It is clear from these considerations that a lead sheet of thickness 100 µm does not
provide adequate shielding from an active source at a distance of z=20 mm directly
above the pinhole. However, with a lead thickness larger than 200 µm, in an ideal
environment ignoring scattering and blurring effects from the pinhole, this model
allows an estimation of the number of counts expected per second depending on
source position in the prostate volume.
It is then possible to create a table with the expected counts per second associated
with position.
The plots shown in Figures 4.5 and 4.6 show the results for a point source moving
in a single Z plane. As the point source is moved in a lateral distance from the
pinhole, the counts at the detector plane can be modelled for different Z distances
as well. As the source is moved further from the collimator, the count rate drops off
exponentially as expected.
The results for locations at Z=10, 15, 20, and 30 mm are shown in Figure 4.7. With
increasing Z distance, the expected count rates drop off, but as shown by the results
in Figures 4.5 and 4.6, the point source signal is distinguishable from the background
noise. Due to the radial symmetry of the system, a calculation in one radial direction
is sufficient to obtain an overview of the overall system. Note that at Z=10 mm,
and X greater than 11 mm the point source is outside the field of view for the single
detector system.
These results show that a collimator thickness of at least 200 µm is sufficient to
absorb the majority of photons from an I-125 LDR seed, except for those directly
through the pinhole aperture.
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Figure 4.3 Images generated from placing a point source of 0.4 mCi at z=10 mm above the
pinhole. Results show counts per second.
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Figure 4.4 A comparison showing two different thicknesses of Pb simulated in MATLAB to
create plots of a point source through a single pinhole.
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Figure 4.5 Counts per second for a moving point source in the X direction. Collimator
simulated is 200 µm thick, and seed kept at z=10mm
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Figure 4.6 Counts per second for a moving point source in the X direction continued. Pa-
rameters as above in Figure 4.5.
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Figure 4.7 Count rate calculated from the placement of a point source at varying X distances
and different Z distances from the collimator.
4.3 Monte Carlo for Pinhole Measurements
This Section outlines the further modelling of the BrachyView system using Monte
Carlo methods. Following the justification of a pinhole collimator thickness as shown
in Section 4.1, an evaluation of pinhole shape must be performed based on analytic
approach. This was done by varying the size of the major and minor diameters of the
cone pinhole and evaluating the resulting projection images obtained on the detector
surfaces.
4.3.1 The Geant4 Monte Carlo Toolkit
The Geant4 (Geometry And Tracking) toolkit (64; 65) is a Monte Carlo code using
object-oriented technology and C++ programming. It describes particle interactions
with matter, developed originally for high energy physics experiments and then ex-
tended to space science and medical physics. Applications in low energy physics are
described by Chauvie et al. (66) and Baro et al. (67) (PENELOPE group- penetration
and energy loss for electrons in positrons in matter).
Geant4 is an open-source, freely downloadable software developed and maintained
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by a large international collaboration based at CERN. It describes electromagnetic
and hadronic interactions with complementary and alternative physics models cov-
ering an energy range from 100 eV up to the TeV scale. The Geant4-DNA package
describes particle interactions down to the eV scale. The extensive physics capability
is coupled with a powerful geometry component that allows the modeling of exper-
iments as large as ATLAS and CMS detectors at CERN, or as small as the DNA
helix.
Geant4 is a toolkit, which means that the user defines the tools for his/her own Geant4
application. The user has to develop a Geant4-based application describing the radia-
tion field, the geometrical configuration and the physics processes of the experimen-
tal set-up. The user can then retrieve the required information from the simulation,
i.e. the energy deposition and the particle fluence in a detector. Geant4 was adopted
in this project to model the response of BrachyView in an I-125 LDR brachytherapy
treatment.
There are seven physics process categories in GEANT4: electromagnetic, hadronic,
decay, photolepton-hadron, optical, parameterisation and transportation. The elec-
tromagnetic processes of photons and charged particles are included in the EM Pack-
age. In particular, Rayleigh scattering, photoelectric effect, Compton scattering, pair
production, ionisation, bremsstrahlung and multiple scattering are modeled in the
energy range from 100 eV up to the TeV scale. Optical photon interactions can also
be described.
The Geant4 Standard EM Package valid down to 1 keV is more commonly used for
High Energy Physics experiments. The alternative Geant4 EM Low Energy Package
is specifically addressed to low energy studies, i.e. medical physics. The G4 Low
Energy Package includes two alternative approaches; one is based on the Livermore
Evaluated Data Libraries (valid to down to 250 eV) and the second one is based on
the physics models of the Penelope Monte Carlo code (valid down 100 eV). The
electromagnetic physics models have been validated with respect to NIST reference
data (68).
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Fluorescence and Auger electrons can also be modelled in the simulation.
In the case of electromagnetic physics, a threshold of production of secondary parti-
cles (cut) has to be defined. The cut is expressed in range; this means that secondary
particles are originated only if their range in a given material is bigger than the cut,
otherwise their energy is considered locally deposited. In the simulation project of
this thesis, the cut was defined to achieve higher simulation execution speed without
sacrificing the accuracy of the simulation results.
Two versions of Geant4 were used in this thesis, Geant4 9.6 and Geant4 10.0.
4.4 The BrachyView Geant4 Simulation
Monte Carlo simulations were performed using Geant4 to model an LDR brachyther-
apy treatment in a water volume representing the prostate.
The simulation was used to determine the resolution of the BrachyView system with
respect to the pinhole geometry. A Geant4 application was developed to model ac-
curately the experimental objects as shown in Section 4.1 (i.e. I-125 seed with lead
collimator and detector system).
The Geant4-based study followed the same approach of the experimental study (as
discussed in Chapter 5). The Timepix and lead collimator system was studied in the
case of a single LDR seed and then extended to a realistic patient LDR treatment
plan.
The Nucletron 6711 brachytherapy seed, described in Section 2.1.2.1, was modelled
accurately in terms of geometry and materials. Photons with an energy spectrum as
illustrated in Table 2.2 were originated in a random position on the seed core, with
randomised direction. Figure 4.8 shows a detailed view of the Geant4 model of the
LDR seed implemented in the simulation. The experimental set-up of the simulation
consisted of a single seed placed in a water volume representing the prostate. When
Simulation Studies 80
Figure 4.8 Single Model 6711 I-125 seed modeled in Geant4. The titanium shell is shown in
red, and the wireframe model shows the inner silver core with the photons generated on this
cylindrical surface, (shown on right).
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Figure 4.9 (Left) Non-isotropic source showing the simulation set-up and concept of lead
collimator absorbing the majority of the primary photons. A small number of photons
pass through the pinhole towards the interaction point in the silicon detector plane. (Right)
Zoomed view of the pinhole showing the cone shape as discussed in Section 4.2.
modelling a realistic LDR treatment, seventy seeds were modelled in the positions as
indicated by the treatment plan.
Timepix was described in detail in terms of geometry and materials. The simulation
model consisted of silicon voxels repeated across a 256×256 array (14×14 mm2) to
model the pixellated detector face of the Timepix detector. The lead collimator was
set below as illustrated in Figure 4.9s, with a thickness of 280 µm equal to the real
experimental collimator. The pinhole was set with a major diameter D of size 800
µm and a minor diameter d equal to 180 µm (see Figure 4.9). The values D and d
characterised the real collimator.
4.4.1 Pinhole Optimisation with one LDR Seed
A lead collimator was defined with three cone pinholes set at 15 mm intervals, cor-
responding to the BrachyView design as explained in Chapter 3. Three individual
modelled Timepix devices were placed 6 mm beneath each pinhole, also in accor-
dance with geometrical considerations of the BrachyView design. A single LDR seed
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Figure 4.10 (Left) Simulation experimental set-up showing a single I-125 seed implanted
in a volume of water. The pinhole collimator corresponds to a single sheet of lead with
three pinholes for three detector planes. The image on the right shows the single seed as an
isotropic source with 2000 primary photons.
was positioned 20 mm directly above the central pinhole, such that three projection
images were obtained on three detector planes corresponding to the three separate
Timepix devices as presented in Figure 3.5. These imaging planes are simulated as
pixellated silicon planes with thickness 300 µm like the real detector, counting events
that reach the detector pixels as shown in Figure 4.10.
4.4.2 Simulation with a clinical LDR brachytherapy treatment
A full clinical LDR brachytherapy treatment was simulated by utilising a real patient
plan with 70 implanted brachytherapy seeds. The simulation experimental set-up
containing the I-125 sources and single pixellated Timepix are shown in Figure 4.13.
The location of these seeds is shown in Figure 4.14, and is based on a real patient
plan provided by St George Cancer Care Centre, Sydney, Australia.
The simulation experimental set-up is shown in Figure 4.15.
By varying the pinhole characteristics (diameter and thickness) a quantification of the
image quality can be obtained. This is done by comparing SNR and image resolution
based on geometric parameters.
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Figure 4.11 Zoomed view of the pinhole geometry modelled in the Geant4 simulation. Vary-
ing the size of the pinhole major diameter (and hence pinhole shape) allows an evaluation of
image blurring effects.
Figure 4.12 Sketch of the lead collimator with a thickness of 1000 µm. Varying collima-
tor thickness allows an evaluation of absorbed and scattered radiation and its effect on the
projection image of the individual I-125 seed and the determination of the centre of mass.
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Figure 4.13 Overview of the Geant4 simulation set-up for 70 seeds in a volume of water.
The I-125 seeds are shown in red, lead collimator shown as a white wireframe, and the single
pixellated Timepix detector shown in dark grey. The image on the right shows the volume of
air between the lead collimator and the detector as a solid grey block immediately inferior to
the collimator.
Figure 4.14 Coordinates of the 70 seeds implanted into an infinite volume of water used to
simulate a realistic LDR procedure.
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Figure 4.15 Coordinates of the 70 seeds implanted into an infinite volume of water used to
simulate a realistic LDR procedure.
Figure 4.16 An example of an overall view showing 2000 primary photons generated from
70 implanted I-125 seeds in a volume of water. Note that 2000 photons were not used for
measurements, but for purposes of figure to show isotropic sources in the volume.
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4.4.3 Optimisation of Collimator by Geant4
By varying the size of the major diameter of the pinhole, count distribution maps
corresponding to the triple detector imaging plane of the experimental Timepix con-
figuration are obtained. Simulations were run for 1 billion primary photons. These
were used to evaluate the size of the pinhole used in experiment and to assess the
amount of noise from collimator scattering and penetration that can result from vary-
ing the geometry of the pinhole.
The results for a lead collimator of thickness 200 µm shows a large amount of scat-
tered radiation (see Figure 4.17) as compared to the signal obtained, and with respect
to the other sizes of collimator evaluated. However, it is noted that the signal to noise
ratio is still favourable for us to distinguish the centre of mass of the seed projections
and therefore perform the necessary calculations for source localisation.
The results from the simulations show that for lead thicknesses more than 200 µm,
the majority of the scattered radiation and background noise is eliminated from the
projection image, as is expected from Section 4.2. The signal-to-noise ratio can be
calculated by number of counts as photons travelling directly through the pinholes as
a ratio against number of counts through lead outside of the pinholes.
The signals shown in Figures 4.18, 4.19, 4.20, and 4.21 have been integrated along
the Y direction through the centre of the pinholes to improve statistics. This was
done in order to assess the signal to noise ratio corresponding to the changing pin-
hole diameter size. In a collimator with three pinholes, three resultant signal peaks
are expected across the entire detector plane. By fitting Gaussian curves to each
source signal peak, the centre of mass of each projection image can be determined
by observing the pixel location at which the peak occurs. However, as shown in the
results the optimal pinhole diameter should be at least 400 µm, which corresponds
with the experimental choice of pinhole used in experimental active seed studies as
described in Chapter 5.
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Figure 4.17 Projection images showing results from a 200µm thick lead collimator. Each of
the images from (a)-(f) show the response from a triple detector configuration with changing
pinhole diameter. The diameters shown are for 200, 400, 500, 700, 800, and 1000 µm.
Detailed profile plots are shown in Figure 4.18.
Figure 4.18 Profiles of the count distribution map as obtained for a collimator made of lead
200µm thickness with varying pinhole diameter. From top left to right, row by row, the
peaks shown indicate a single seed as viewed by three detectors through three pinholes. The
pinhole diameters are from 200-1000 µm in 100 µm increments. Note the low SNR for this
thickness due to penetration through the thin lead collimator. Blue represents integral counts
as a function of pixel distance, and red represents the automatic identification of peak values
by MATLAB.
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Figure 4.19 Profiles of the count distribution map as obtained for a collimator made of lead
300µm thickness with varying pinhole diameter. Compared to 200 µm as shown in Figure
4.18, there is a much higher SNR, allowing the identification of the peaks corresponding to
the centre of mass of the I-125 seed.
Figure 4.20 Profiles of the count distribution map as obtained for a collimator made of lead
400µm thickness with varying pinhole diameter. Similar as shown in Figure 4.19, a high
SNR is achieved, however, a larger pinhole diameter is required to overcome the geometric
thickness of the collimator. The outermost peaks are not visible until a pinhole diameter of
700 µm.
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Figure 4.21 Profiles of the count distribution map as obtained for a collimator made of lead
500µm thickness with varying pinhole diameter. As shown in Figure 4.20, a larger thickness
requires a larger diameter for suitable SNR and seed centre of mass identification.
4.5 Summary & Conclusion
An analytic method was employed. A point source corresponding to a 0.4 mCi I-125
source was successfully modelled in MATLAB based on geometric parameters of
the BrachyView system consisting of user-defined pinhole collimator and detector
parameters. Specifics of the detector system which can be modified include:
1. Collimator thickness;
2. Pinhole diameter;
3. Collimator-detector distance;
4. Number of pixels in detector;
5. Source position;
6. Source activity.
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Geant4 simulations were performed to obtain a characteristaion of image quality on
the Timepix detectors as a function of pinhole parameters. Energy parameters used
were the same as to be expected from a typical LDR I-125 brachytherapy source,
including primary photons ranging from 25-32 keV and fluorescent X-rays at 27 keV
(as explained in Section 2.1.2.1). By varying the thickness of the collimator as well
as pinhole diameter, an optimal thickness between 200-400 µm was found, allowing
a large SNR for determination of the centre of mass of each seed projection image.
For our purposes, this allows us to use a theoretical model indicating the optimal
thickness of collimator and pinhole size to obtain an optimal signal for source local-
isation based on the projection images obtained. While this initial model utilises a
simple circular (i.e. cylindrical) pinhole, and ignores blurring and penetration issues
at the pinhole edge, it is a useful preliminary indicator. Furthermore, the possibility
of determination of centre of mass of each implanted seed is confirmed with the im-
plantation of each nth seed preceded by the subtraction of background of (n-1) seeds.
The centre of mass of each projection image was determined manually by operator
selection.
Furthermore, it can also be used to create a reference system for calculating the ex-
pected count rate at the detector surface based on source position. When compared to
the results obtained in the pinhole study in Chapter 5, there is a qualitative agreement
between what is modelled and what is experimentally measured.
Future work involves undertaking further simulation to introduce higher statistics
into the results. Due to the small physical size of the pinhole, and the low energy
of incident photons, simulations take a large amount of time to compute before sat-
isfactory results are obtained (a simulation consisting of 1 billion primary events
yielded statistics less than 50 counts at detector surface, as shown in Figures 4.17-
4.21). However, from these calculations, it is evident that the optimal thickness for
the pinhole collimator is between 200-400 µm with major diameter equal to less
than 1 mm, and minor diameter greater than 100 µm. Variance reduction techniques
should also be employed in future work to increase precision and speed up the simu-
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lation process. One example could be to pursue stratified sampling and implement-
ing anisotropic sources to direct all primary photons to travel directly to the pinhole.
However, this would not account for intra-organ scattering, which is not dosimetri-
cally negligible.
The analytic and simulation work can be used as a reference system to calculate ex-
pected approximate experimental values and projection images on Timepix detectors.
The simulation results were ultimately used as a guide for experimental manufactur-
ing of collimator and geometrical set-up.
Chapter 5
Experimental BrachyView Feasibility
Study
This chapter presents the experimental work performed using a lead collimator and
single Timepix detector. Utilising real active LDR sources in plastic and gel phan-
toms, a proof-of-concept study was conducted, proving the feasibility of the proposed
approach in BrachyView for localising implanted sources in 3D. Therefore, the lo-
calisation algorithm used in BrachyView can be tested and evaluated; initially with a
small number seeds, but increasing to a more clinically realistic scenario involving a
larger number of seeds.
5.1 Phantom Design
The phantom is a 60×60×40 mm3 polymethyl methacrylate (PMMA) cube. PMMA
is a transparent acrylic glass compound that is often used as an approximation for
human tissue, with a density of 1.18 g/cm3. The phantom design is a simplified rep-
resentation of the brachytherapy implant that utilises one main feature: the implant
template coordinate system.
Figure 5.1 shows a typical brachytherapy template in which a grid system of coordi-
nates is used to distribute the brachytherapy sources in their designated areas in the
prostate according to the treatment plan. Each adjacent letter and number represents
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Figure 5.1 Left: Sketch of a typical brachytherapy template with needle inserted through
position d6.5 (from US Patent). Right: Photograph of a disposable model as manufactured
by Civco Medical Solutions (Image courtesy of Civco).
a spacing of 10 mm, with an intermediate hole located midway between at 5 mm
represented by lower case letters and decimal place of 0.5.
Following the ultrasound-guided volumetric study and assessment of the required
distribution of brachytherapy seeds, the implant needles are planned and ordered
ahead of time. Every implant needle is pre-loaded with the number of seeds required
in the specific location according to the patient-specific treatment plan and is inserted
through the corresponding coordinate to be implanted through the patient’s perineum
(see Figure 2.11. The needle tip is guided by ultrasound imaging and the seeds
deployed by the brachytherapy practitioner needle by needle. The positions in the
central region around location D4 are usually left empty to avoid delivering dose to
the intraprostatic urethra. The labelling of intermediate points are notated as lower
case letters and decimal points, e.g. E3.5, c1, a2.5, and F5.
An alternate phantom was also designed containing a larger number of implant holes,
and this was used in experiments involving a larger number of seeds, discussed in
Section 5.6.
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Figure 5.2 The PMMA phantom showing holes drilled for housing brachytherapy sources in
experiment and the simulated grid template with pitch 10mm.
Figure 5.3 Scanning electron microscope image of lead pinhole used in experiment. The
image on the right shows the inner diameter measures to approximately 180 µm. The outer
diameter of the pinhole is approximately 800µm
5.2 Pinhole Collimator Design
The pinhole collimator used was developed at the Centre for Medical Radiation
Physics (CMRP) and consists of a cone-shaped lead structure. It was created by
inserting a stainless steel needle tip into a sheet of lead. A scanning electron micro-
scope image of the pinhole aperture used in experiments is shown in Figure 5.3 and
Figure 5.4 shows a photo of the experimental triple pinhole lead sheet collimator.
The combination of a single Timepix detector and pinhole collimator was designed
to have a minimum field of view of approximately 50 mm at a distance of 10 mm
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Figure 5.4 Photo of the experimental pinhole sheet used. Three pinholes spaced 14 mm apart
correspond to the triple detector design of BrachyView as shown in Figure 3.5
.
given by the relation as described by Beekman et al. (11):
FOV ≈ 2 · l · tan(θ) (5.1)
where l is the source-to-collimator distance) and θ is the angle formed by the aperture.
In this experimental study, the pinhole aperture was measured at ±50.5◦, with the
aperture forming the shape of a truncated cone with large face (major) diameter D,
small face (minor) diameter d, and thickness T as shown in Figure 5.5). This con-
dition was established based on the minimum distance between the inner rectal wall
and the prostate, which is typically in the range between 4-10 mm. The thickness
T of the lead plate is approximately 400 µm based on the parameters established in
Chapter 4 which leads to the most effective attenuation of the photons emitted by the
I-125 LDR sources.
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Figure 5.5 Model of the pinhole used for the design of the collimator system in BrachyView
Using the model of Figure 5.5, the count rate N can be estimated by considering
the product of the portion of solid angle of a point source with activity A (decays/s)
at distance R from the detector surface. The seed has been represented by a point
source, identified in the centre-of-mass of the seed, since the aim of this study is
the evaluation of the performance of BrachyView for the reconstruction of the seed
position regardless of its orientation.
N = A • Ω • σSi (5.2)
where Ω = πr
2
R2
, r is the radius of the projected area through the pinhole and σSi is
the total efficiency due to Compton and the photoelectric effects in silicon detector
for 27 keV gamma photons and Si detector thickness 400 µm (approximately 60%
[NIST (National Institute of Standards and Technology) value]).
Considering a typical brachytherapy source with air KERMA strength 0.5 U, which
corresponds to an intrinsic activity of 0.4 mCi, it is found that for an aperture of
d=180 µm the expected count rate of the gamma camera exposed to a seed located at
source-to-collimator distance of 50 mm would be approximately N=2700 counts/s.
This calculation shows that the geometry and dimensions of the system make possi-
Experimental BrachyView Feasibility Study 97
ble the use of the gamma camera for fast seed positioning determination, especially
when only a few hundred counts are sufficient to discriminate the seed projection
from the background noise (this is experimentally verified as shown in Section 5.4 as
well as in simulations as shown in Chapter 4).
5.3 3D Localisation Method
The three-dimensional position of each seed is reconstructed by using a stereoscopic
back-projection technique based on tracing lines between the pinholes and the centre
of mass of the digitised 2D images of each seed on the detector plane. Note however,
that the position of the detector inside the rectum has two major consequences in
terms of image reconstruction:
1. The detector cannot be rotated around the target region and so a standard image
reconstruction technique such as the multiple back-projection used in SPECT
scanners cannot be adopted;
2. Due to space restrictions, the pinhole camera has a magnification factor less
than 1 and therefore an imaging sensor with a high spatial resolution is neces-
sary.
The back-projection reconstruction used for BrachyView is based on the use of 2D
images generated by the incident gamma rays from the seed projected onto the sensor
plane through the pinhole collimator. The pinhole is identified as the origin of the
camera frame (Xc0, Yc0, Zc0).
The resulting image is the projection of a 3D object onto the detector plane assuming
that each point of the object emits a gamma photon. To a first approximation, the
image of the object can be represented by its centre of mass ignoring, at this stage,
any information about its orientation. All images are obtained by working with the
Pixelman software. Pixelman is a software package developed by the Institute of
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Figure 5.6 Pixelman software showing a projection image of a single Timepix detector
(256×256 matrix). Data can be saved as image files (.jpg, .png etc), or as ASCII matrices.
The image shown is of 20 seeds discussed in a later section.
Experimental and Applied Physics, Czech Technical University in Prague (IEAP). It
supports all available Medipix2 and Timepix-based hardware. By interfacing with a
USB readout (via a FITPix connector as shown in Figure 2.23, all data is displayed
on-screen in real-time as shown in Figure 5.6. All the electronic settings of the
attached detector chip, such as THL levels and frame length and frequency, are set
using Pixelman. Data can be saved as image files or as raw ASCII matrices, with
each number corresponding to one pixel of data.
By acquiring at least two images of the object from two different positions of the
pinhole collimator (i.e. two different pinholes), it is possible to reconstruct the object
position in real space by determining the point of intersection of the lines calculated
by back-projecting from the 2D image through its corresponding pinhole. By con-
sidering the coordinates of the centre of mass of the images and the pinholes, object
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localisation can be performed. Furthermore, the accuracy of reconstruction can be
increased with a larger number of pinholes and projection images. For the purposes
of this study, three pinholes were used in experimental measurements.
The system ’object-pinhole-2D projection’ can be represented by a simple model that
describes the mathematical relationship between the coordinates of the 3D point Pc
in the pinhole camera frame (Xc, Yc, Zc) and its projection P1 onto the image plane
(x, y) as shown in Figure 5.7. This model is based on the use of an ideal camera
without lenses and thus without spherical distortion.
In Figure 5.7, the image on the left represents the first projection of the seeds. Note
that in this position, the seed located in position D3 is immediately blocked by the
seed in position B3. Therefore, in the resulting image on the detector plane, only
three of the four implanted seeds are visible. In the image on the right, the grayed
image plane represents the first projection. Now all four seeds are visible on the
image plane following a translation step in the Y direction (longitudinal direction) of
the probe - i.e. with multiple views, all the seeds can be resolved successfully. In the
case where multiple detectors are not possible, the translation can be achieved with
a single detector-pinhole system, as is explained in Section 5.4.
Introducing the value f for the focal length of the set-up (i.e. the collimator-detector
distance) allows us to express the geometric relationship between (Xc, Yc, Zc) and
(x, y) by the focal length fx = fy = f , assuming no astigmatic aberration in the
system (square pixel size, square pixel array, cylindrical symmetry of the pinhole)
(14):
x = f
Xc
Zc
, y = f
Yc
Zc
(5.3)
If the origin of the image coordinate system is not in the centre of the image plane,
the displacement (s1, s2) from the origin to the centre of the image plane is included
in the projection equations, obtaining the perspective projection equation below. The
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Figure 5.7 Schematic representation of the homogeneous coordinate model and reconstruc-
tion method by triangulation.
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Parameter Symbol Value
Focal length f = fx = fy 5.5 ± 0.1mm
Relative X translation P-to-pinhole s1 0
Relative Y translation P-to-pinhole s2 Steps of ±5 ±0.01 mm
2D projection image centre of mass (x,y) Calculated by a Gaus-
sian fit of the pixel map
Table 5.1
Intrinsic parameters of the homogeneous coordinate model as implemented in MATLAB.
parameter si could represent any movement of the point Pc relative to the pinhole.
x = f
Xc
Zc
+ s1, y = f
Yc
Zc
+ s2, z = Zc (5.4)
The previous relation can be reformulated using the projective geometry framework:
(αx, αy, α)T = (fXc + s1, fYc + s2, Zc)
T → P1 = HPc, (5.5)
where α = Zc is a homogeneous scaling factor, and H is the intrinsic conversion
matrix composed of the parameters which characterise the pinhole-imaging plane
apparatus in the camera frame.
The above model was implemented in MATLAB and intrinsic parameters were set
with the values used for the experimental set-up as shown in Table 5.1.
Rays are drawn from the projected seed image on the image plane (centre-of-mass
projection) through the centre of the corresponding pinhole. This process is repeated
for each time the pinhole/detector is moved relative to the source. Since skew lines
in 3D do not necessarily intersect, the seed coordinate Pc is taken to be the midpoint
of the shortest chord joining the two projected rays.
This method creates a dataset of 3D coordinates of seed positions within the prostate
gland. The next crucial step is to make this data clinically relevant. Although the in-
tegration of the two devices in a single instrument is challenging from an engineering
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standpoint, the co-registration of the datasets is a relatively straightforward task. By
relating ultrasound data and Timepix-pinhole data via a common spatial coordinate
frame, a co-registration can be performed. This method (albeit with CT data, but
the concept remains the same) is discussed in Section 5.6. Note also that TRUS and
BrachyView can be used separately; TRUS for volumetric studies and planning, and
BrachyView for seed localisation (such as a dual-probe approach as described by Ali
et al. (69).
5.4 Pinhole Experiment Set-up
Seed position reconstruction techniques have been tested with the use of a 60×60×40
mm3 PMMA prostate phantom. Parallel channels for housing of the I-125 seeds
were drilled into the phantom following the grid template used in LDR TRUS-guided
brachytherapy procedures (as shown in Figure 5.1).
For this proof-of-concept study, a single Medipix2 with imaging area 14x14 mm2 and
a single pinhole lead collimator was used. The phantom was attached to a motorised
stepper, and translated relative to the pinhole/detector system in order to achieve
multiple images of the same seed distribution. In this experiment, five pinhole loca-
tions above the imaging plane were modelled by using five separate projections. The
schematic and a photo of the experimental set-up are shown in Figures 5.8 and 5.9.
A configuration of four seeds (Model 6711 I-125 Oncura/GE Healthcare, Princeton,
USA) with strength 0.05 U was placed in positions B1, C2, B3, and A4 of the phan-
tom (see Section 5.2). Images were acquired for 3 seconds at 50 frames/s. This was
used to evaluate the spatial resolution of BrachyView and estimate the effective di-
ameter of the pinhole collimator. The seeds were positioned in three different rows
for three main reasons:
1. Evaluate the effect of the source to collimator distance (SCD);
2. Evaluate the projected image quality of two seeds positioned simultaneously:
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Figure 5.8 Model of the pinhole used for the design of the collimator system in BrachyView.
one in B3 (close to the detector, and hence bright), and one in C2 (far from the
detector and hence weaker);
3. Verify the extension of the field of view when a seed is placed in the periphery
position (for example, A4).
The spatial resolution and effective diameter of the pinhole (deff ) were evaluated
assuming a Gaussian fit of the projections of the seeds onto the Medipix2 detector
imaging plane. Due to the alignment of the detector relative to the phantom, the num-
bers in the Y-direction correspond to the column numbers of the Medipix2, which are
perpendicular to the long axis of the seeds. In this case, the seeds appear horizontal
on the projected image generated by the detector.
Note that the activity of seeds used in experiment are 10 times less than normal in
clinical practice. Therefore the time required to obtain necessary imaging statistics
would be much faster in a real patient implant.
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Figure 5.9 Photo of the experimental set-up showing PMMA phantom attached to motorised
stepper. (a) shows the anterior view including the grid template designed to mimic a sim-
plified prostate brachytherapy implant grid template. (b) shows the superior view including
the motor stepper system movement directions used to simulate the presence of multiple
detectors.
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Figure 5.10 (a) Response map of BrachyView to four seeds placed into positions B1, C2, B3,
and A4 of the phantom, and (b) the response profile at column Y=120 and fit by Gaussian
distribution for calculation of the spatial resolution FWHM.
5.4.1 Resolution Evaluation
Before considering the 3D localisation of the active sources in the phantom, the res-
olution capabilities of the pinhole were investigated. Figure 5.10 shows the response
map (image plane) of the system with four seeds in position. The response function
can be represented by a plot by selecting one of the pixel columns (perpendicular to
the X direction). For example, in Figure 5.10(b), the position Y=120 was selected
to create the intensity profile. The intensity distribution of the counts in the pixels
along the X direction can then be used to calculate the spatial resolution. Taking the
pixel size and the focal length into account, the effective diameter of the pinhole can
therefore be determined.
The precision of 3D position reconstruction can be defined by the combination of the
transverse and the longitudinal accuracy. Transverse accuracy εxy is the degree of
closeness of the reconstructed position of the seed to the expected value in the XY
plane (parallel to the collimator plane). This can be obtained by the back-projection
of the centre of mass of the projection image through the pinhole. This quantity is
related to the spatial resolution achievable in the plane of the detector, (Rp), and it
depends on the dimensions of the pinhole, (deff ), in the pinhole camera resolution
Rt.
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Figure 5.11 Comparison of the FWHM values obtained from the experimental response map
of the BrachyView (solid squares) and transverse accuracy in the XY plane (solid triangles)
for different Z positions of seeds and predicted by the model from Beekman and van der
Have (14) and Marks and Brady (15).
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The spatial resolutionRp as a function of the SCD and the overall transverse accuracy
εxy are plotted in 5.11 (c) (dashed and solid line, respectively). εxy matches the
experimental data for a value of the effective diameter of the pinhole (deff ) equal to
350 µm.
εxy =
√
R2p +R
2
t =
√[(
l
f
p
)]2
+
(
deff (l + f)
f
)2
(5.6)
Equation 5.6 is derived from geometric considerations and is entirely defined by the
camera parameters: p is the detector pixel size, l is the SCD, deff is the effective
pinhole diameter and f the focal length. The result obtained by Beekman and van der
Have (14) is confirmed also by the work of Marks and Brady (15) based on the
3D Fourier transformation of intensity maps of the source projected by a pinhole
collimator. The comparison of the transverse accuracy calculated by Equation 5.6
and measured by BrachyView is plotted in Figure 5.11.
Experimentally, Marks and Brady (15) constructed a pinhole camera with a 300 µm
diameter pinhole. The 3D data sampled was obtained by capturing the intensity of
the source volume behind the pinhole as a function of transverse camera position.
The model developed by Marks and Brady (15) also allows the calculation of the
accuracy along the Z direction based only on the fundamental camera parameters:
εz ≈
l3 · d
f 2 · s2
(5.7)
where s2 is the increment used for translation of the camera relative to the source.
The longitudinal accuracy of BrachyView calculated by this model ranges from±0.2
mm at 10 mm SCD, and up to ±6 mm at 60 mm SCD (corresponding to the superior
and anterior sides of prostate gland). These values indicate an accuracy range well
within acceptable clinical expectations for an effective brachytherapy implant for all
sizes of the prostate gland.
Some further examples of images obtained of fully loaded rows are shown in Figure
5.12.
Experimental BrachyView Feasibility Study 108
Figure 5.12 Rows A-E contain 5 positions each according to the phantom design as shown
in Figure 5.2
5.5 Feasibility Study of 5 Active Sources
Using the set-up as shown in Figures 5.8 and 5.9, the reconstruction algorithm was
employed to reconstruct the 3D position of the five seeds. Five active sources of
intrinsic activity 0.4 mCi were placed in the phantom at positions A2, A4, B1, B3
and B5, within the field of view of the detector plane. The phantom was then trans-
lated at 5 mm increments in order to obtain the separate projection images necessary
for 3D position reconstruction. The projection images were analysed to obtain 2D
coordinates of the centre of mass, and each end of the seed, to create a 3D recon-
struction of each seed and its corresponding active source length. These results were
then compared to expected positions as considered from their positions in the PMMA
phantom.
The seeds were placed in different positions in the XZ plane within the phantom, with
the same Y value. The position of the seeds was chosen to test two parameters that
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were identified as having potential negative effects on the reconstruction technique:
1. Blurring of the image and increasing of the background counts generated by
scattered and penetrating photons through the lead collimator. This is particu-
larly significant when the seeds are in close proximity to the collimator (seeds
located in rows A and B);
2. Evaluate the image generated by seeds blocked by other seeds, i.e. the config-
uration with one seed in B1 and one is A2 is of interest because B1 is masked
by A2 in some of the projections. This is the so-called screening effect.
Reconstruction was carried out through the use of five projections corresponding to
a translational shift of the phantom at distances of -10, -5, 0, 5, and 10 mm from the
origin in the Y direction. The first image was taken with the centre of the detector
aligned with the phantom in the position Y= -10 mm. Each successive image was
taken at a 5 mm incremental shift of the detector-pinhole set-up towards positive Y.
This technique mimics the use of a multiple pinhole collimator and a detector surface
equivalent to a multiple Medipix2 configuration. The projection images obtained are
shown in Figure 5.13.
The technique of translating the single detector/pinhole system is illustrated in 5.14.
By determining the centre of mass of each seed projection image, as well as the
corresponding edges of each seed, the position of the implanted active I-125 source
is calculated in the 3D coordinate system and compared to the expected positions in
the PMMA phantom. The calculated results are shown in Figures 5.15, 5.16, and
5.17.
The accuracy of 3D coordinate reconstruction decreases with the distance of the
source from the collimator (SCD), however the centre of the seeds placed at row
E corresponding to 60 mm SCD can still be fully resolved and localised with an
accuracy of approximately 3 mm (see Figure 5.18).
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Figure 5.13 Projection images showing 5 implanted seeds at positions A2, A4, B1, B3, B5.
The shape of each seed is clearly visible. Note that in the third image at the top, the seeds in
positions B1 and B5 are blocked from view by seeds in row A. Each view is taken at 5mm
increments along the Y-axis.
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Figure 5.14 Reconstructed seed positions for seed A2 shown in three dimensions. The green
star represents the expected position and the red stars represent the reconstructed position
based on different views through pinhole positions Q and S at 0, 10, 15, and 20 mm as
translated here in the X direction.
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Figure 5.15 Reconstruction of the five seeds in PMMA phantom showing one particular
perspective. The XZ view corresponds to the anterior surface of the phantom.
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Figure 5.16 The YZ view corresponds to the longitudinal view of the phantom (i.e., side-on).
Figure 5.17 The XY view corresponds to the superior view of the phantom (i.e., top-down).
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Figure 5.18 Medipix response map of five seeds implanted at positions E1, E2, E3, E4 and
E5. Note that the shape of each seed is no longer visible, but the centre of mass can still be
resolved, allowing for use in 3D reconstruction of seed position.
These results show that 3D reconstruction of I-125 seeds using a pinhole camera
inserted into the rectum is feasible with some limitations dictated by the specific set-
up used in these experiments. The main parameters characterized in this work are
the transverse and longitudinal resolution of the camera.
The transverse spatial resolution measured at low SCD is in the sub-millimetre range
and matches the requirements for accurate localisation of the source. On the other
hand, for a 60 mm SCD the resolution is approximately 3 mm which seems to be
inadequate for accurate position reconstruction of the seeds. This limitation can be
addressed by the employment of a tungsten pinhole collimator manufactured by laser
etching techniques which will reduce the effective pinhole diameter down to 150
µm (real pinhole diameter size down to 100 µm). The estimation of the count rate
N will still be acceptable with 2700 counts/s but the transverse resolution will be
substantially improved (2 mm transverse resolution at SCD of 60 mm, accordingly
with the Marks and Brady (15) model described in Equation 5.6).
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The longitudinal resolution is, by comparison, very robust. It is affected only by the
focal length (α1/f 2) which therefore must be determined very accurately. Data in
Figure 5.17 show that the effect of an uncertainty of 100 µm on the focal length gen-
erates a variation (vertical error bars) of the seed reconstructed position in Z of less
than 1 mm. The horizontal error bars are calculated by the model for the transverse
accuracy of Equation 5.6). The model predicts the uncertainty obtained in the exper-
imental data and confirms the importance of accurate manufacturing of the pinhole
collimator to optimize the 3D reconstruction accuracy.
All the parameters have been investigated assuming a linear source embedded in the
titanium shell and its projection is simplified by the identification of the center of
mass of the seed image. This approach should still be valid for other designs of
brachytherapy seeds, such as those with their radioactive material embedded in small
beads encapsulated within the titanium shell. Photon scattering in the Ti shell of
the seed will smooth the effect of the discrete distribution of the radioactive material
inside the seed especially at high SCD and the approximation of the seed projection
profile by a Gaussian fit should still be possible.
5.5.1 Summary & Conclusion
Studies using a high spatial resolution silicon detector for miniature in-body pinhole
gamma camera have identified an opportunity for dynamic IO treatment planning in
permanent prostate brachytherapy. A preliminary characterisation of the BrachyView
concept and reconstruction technique has been carried out by the use of a single
Medipix2 and a Timepix sensor coupled with a single pinhole collimator. The seed
position reconstruction method is based on triangulation of the image map of the
seeds projected onto the imaging surface through several pinholes.
Proof of the feasibility of this approach was carried out using Model 6711 I-125
seeds placed at different locations in a PMMA phantom. The method demonstrates
the feasibility of the 3D reconstruction of the seed centre of mass position with an ac-
curacy higher than 1 mm for seeds located within 20 mm of the collimator. A model
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for estimating the 3D reconstruction accuracy based on the fundamental parameters
of the camera has been implemented and validated by measurements.
The main advantage of this technique we would like to highlight in this work is the
possibility to co-register the 3D dataset obtained by the pinhole camera with the im-
ages of the prostate obtained by the TRUS probe. The overall dimensions of the
pinhole gamma camera are small enough to be integrated within a 25-30 mm diame-
ter cylindrical probe which still represents an acceptable size for use with patients.
Further developments of the BrachyView project will attempt to improve the quality
of the pinhole collimator using tungsten laser etching technology, manufacturing of
the multiple-chip Medipix detector on a single substrate and to integrate the high spa-
tial resolution gamma camera with a TRUS probe. Future work will also include the
development of a reconstruction method based on the use of seed pattern recognition
to identify the orientation of the seeds and software development for the imaging of
multiple seeds in a realistic clinical scenario.
The use of imaging techniques from the nuclear imaging field such as a coded aper-
ture pinhole collimator combined with the well-known geometry of the distributed
activity in a seed would simplify the reconstruction of around 100 seeds typically im-
planted into a prostate for a realistic treatment plan. This new device could condense
prostate permanent implant brachytherapy into a single procedure whereby volumet-
ric study, intraoperative dynamic treatment planning, and post-implant dosimetry are
all performed by a single device.
5.6 Using 20 Active Sources and Comparison with CT
An additional study was completed to test BrachyView’s compatibility with a larger
number of seeds implanted into a prostate phantom. Using a stepper motor system
mounted on a portable optical table, the phantom was incrementally loaded with ac-
tive seeds up to 20 individual sources. These sources were located at positions B3,
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C2, c3.5, D2, E2, and F3 as shown in Figure 5.19, using a similar PMMA phan-
tom as described in Section 5.1. The implant template used in this experiment was
the CIVCO LDR sterile 17GA Grid for 1.3 mm diameter open-ended needles and
consisted of a grid of 11x11 holes with 5 mm spacing in between each as shown in
Figure 5.1. The detector used for this study was a Timepix.
The seeds (Model 6711 from Oncura) had an air KERMA strength of 0.5 U corre-
sponding to an intrinsic activity of 0.4 mCi, as is typical for a standard LDR prostate
brachytherapy procedure. The distribution of the seeds was designed to mimic a
typical treatment plan, leaving a gap around the theoretical position of the intrapro-
static urethra. Due to the large number of active sources being used, this work was
done in a shielded CT room with under the guidance and advice of the brachytherapy
practitioners at St George Cancer Care Centre.
The needles were implanted following the clinical procedure of implantation starting
from the top left corner and progressing from left to right: c3.5, d3.5, B3, F3, C2, D2,
E2. Thus the images acquired by the single Timepix detector showed the progression
of the implant as it occurred. This allowed us to test the system’s capability to resolve
multiple seeds as the number of total implants gradually increased.
The time interval between implantation of two needles is approximately one minute
(for an experienced oncologist) which represents the time frame available for the
acquisition by the gamma camera of the photons emitted by the set of seeds in one
needle. This time frame, with full active seeds can produce clear projections of each
seed as shown in the results.
A single Timepix device was used in this study with a single pinhole in a sheet of
lead 0.5 mm thick. Using a high accuracy motor stepper (a similar set-up as described
in Section 5.4), the Timepix-pinhole system was translated at 15 mm increments in
order to mimic the presence of a true multi-chip assembly, as discussed in a previous
section. The pinhole used in this study was a lead cone pinhole with major diameter
of 800 µm and minor diameter of 400 µm.
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Figure 5.19 Schematic showing 60×60×60mm3 PMMA phantom and the distribution of 20
active seeds, indicated by the grey circle. The number of seeds implanted in each position
are indicated by the white numbers.
Figure 5.20 Photo of the experimental for multiple seed set-up showing single Timepix de-
vice attached to motorised stepper
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Figure 5.21 Projection images showing the progression of the implant as each needle is
loaded into the platform. Images are shown in a colour scale corresponding to counts ob-
tained.
The single Timepix was aligned with the phantom by positioning a single active seed
in the D2 position at the centre of the phantom and aligning the projection of the
seed with the central pixel of the detector corresponding to position (128,128). The
coordinate sysem of the gamma camera has its origin defined as the position of the
central pinhole, which is aligned with the central pixel of the imaging plane.
Using the reconstruction method as discussed in Section 5.3, the positions of the 20
seeds implanted in the PMMA phantom were found within 1-2 mm accuracy. The
projection images obtained at the first position corresponding to Y=0 mm are shown
in Figure 5.21, with each progressive needle implant showing a gradual increase in
counts and a corresponding increase in background noise from scattered events. Note
however, that the seed projection image and shape can be easily resolved against the
background even up to the last implant of the 20th seed. The order of the needle
implants correspond to the locations: c3.5, d3.5, B3, F3, C2, D2, and finally E2
containing 3,3,2,2,3,4, and 3 seeds in each needle location respectively.
The images in Figure 5.21 show a single Timepix and pinhole. By tiling each single
image together, a ’single acquisition’ image can be considered, showing what a true
multiple detector assembly would be able to visualise. Considering there is space
between each detector, corresponding to the translation required to cover the field of
view, this can be represented as shown in Figure 5.22. The centre of mass of each
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Figure 5.22 Triple detector image obtained by positioning each single projection image.
By knowing the lateral shift of each detector, the multiple chip assembly can be accurately
modelled and the localisation of the centre of mass of each seeds projection image can be
used to calculate the 3D localisation of each seed within the phantom.
seed is indicated by the yellow crosses.
Once the pinhole measurements were completed, a full CT scan using a medical CT
scanner was performed to obtain a benchmark reference for seed position reconstruc-
tion. The scanner used was a Siemens CT SOMATOM Emotion 120kV with 0.8 mm
resolution (brain mode). For the purposes of this study, the CT scan was performed
with a slice width of 0.8 mm, which is much smaller than used in typical medical
scans, allowing us to obtain 3D reconstruction results with a higher accuracy.
The CT results were visualised to emphasise bone density; i.e. reduced contrast with
no saturation for high electron density materials such as iron, steel and titanium in
comparison to PMMA. This set-up reduces the saturation of the grey scale and the
effect of the artefacts generated by the interaction of the X-rays from the CT-scan
with high density materials in the experimental set-up, such as the pillars of the
optical bench.
For co-registration with the CT scanned images, a different coordinate system was
proposed. By taking the two outermost seeds (positions B2 and F2) and obtaining an
average (i.e. the middle distance) between these two positions, a new origin is defined
as lying on the line between. This was proposed as an alternative to using a single
seed as a reference marker, which could lead to unknown degrees of uncertainty
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Figure 5.23 CT scan showing the distribution of the 20 seeds at the baseline slice (seeds de-
posited at greatest Y depth in the phantom). Each CT slice corresponds to 0.8 mm thickness.
around that origin. This method of co-registration of images is similar to that of the
point-to-point registration as described in previous studies, for example by Polo et al.
(42) and Gong et al. (46).
In this way, the Timepix-pinhole results are able to be checked against and co-
registered with the CT reconstructed seed positions, and the approach for BrachyView
in use of a multiple seed scenario verified.
A slice of the CT scan is shown in Figure 5.23.
The results of the source localisation are shown in Figures 5.24,5.26, and 5.25 as
orthogonal projection views. The results are shown as a comparison between the
Timepix-pinhole system and the CT reconstructed data.
The co-registration is performed as follows. By defining the midpoint between the
two outermost seed positions (B3 and F3) as the origin of the coordinate system,
the dataset containing information for the reconstructed seed positions can be com-
pared between those obtained by the gamma camera BrachyView and those from the
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Figure 5.24 Reconstructed 3D coordinates for implanted seeds shown in orthogonal projec-
tions, comparing values obtained from the Timepix-pinhole system, and the clinical CT scan,
in superior view (corresponding to XY).
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Figure 5.25 Reconstructed 3D coordinates for implanted seeds shown in orthogonal projec-
tions, comparing values obtained from the Timepix-pinhole system, and the clinical CT scan,
in superior view (corresponding to XZ).
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Figure 5.26 Reconstructed 3D coordinates for implanted seeds shown in orthogonal projec-
tions, comparing values obtained from the Timepix-pinhole system, and the clinical CT scan,
in superior view (corresponding to YZ).
clinical CT scan.
An additional visualisation method has been developed to allow a better perception
of the accuracy of the implantation by the physician who may be unfamiliar with the
use of the Timepix detector. The method consists of the use of the seed centre of
mass reconstructed by BrachyView to generate a 3D model of the seed population
(indicated by the red seeds in Figure 5.27). The model is based on known dimensions
and shape of the implanted seeds. Figure 5.27 shows the model calculated with the
centre of mass of the seed population co-registered with the 3D CT of the phantom
reconstructed from the DICOM slices. A selective high CT number filtering has
been applied to isolate the titanium shells of the seeds from the surrounding water-
equivalent materials. This fiducial-based rigid registration method which will be
effective in this application not only for the CT post-implant verification but also for
the TRUS dataset. The co-registration is discussed above.
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Figure 5.27 3D reconstruction and co-registration of the BrachyView analytical model of the
seeds and the seeds as reconstructed using the CT scans.
5.6.1 Background Noise Consideration
Increase of the background radiation with the number of seeds implanted can be
taken into account using a subtraction methodology: after each needle implantation,
the frame (N) is recorded and acquisition of the new map restarted (frame N+1).
Counts of the frame N are then subtracted to the frame N+1. The net count map
is then used to identify the seeds implanted during the frame N+1. The subtraction
procedure follows the implantation routine and maintains the background counts at
an almost constant level despite the increase of the number of seeds implanted. The
results of this analysis are shown in Figure 5.28.
5.7 Gel Phantom Study
Finally, measurements using a number of active seeds implanted into a gel phantom
allowed us to evaluate the efficacy in another step towards a realistic clinical scenario.
The PMMA phantom studies as described in previous sections prove the feasibility
of the application of BrachyView for use in brachytherapy source localisation, but
these phantoms are rigid and do not represent a malleable organ accurately.
By extending these feasibility studies to the use of a soft tissue-equivalent gel phan-
tom, and by using a TRUS probe as used in actual PPB procedures, we are able to
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Figure 5.28 Background measurement with and without previous frame subtraction. Frame
subtraction guarantees a better signal to noise ratio in a multiple seed scenario.
evaluate the system’s capability to localise sources displaced due to deformations in
the soft tissue arising from the presence of the TRUS probe. The gel phantom used
is a tissue-equivalent medical ultrasound phantom developed by Computer Imaging
Reference Systems (CIRS). It is also used in the experimental study described in
Chapter 7.
The aim of this study as shown in Figure 5.30 is to reconstruct the position of active
seeds implanted into the gel phantom by two methods: conventional CT scanner
and Timepix single sensor. The conceptual approach is similar to that as described
in Section 5.6, but in a medical tissue-equivalent phantom featuring anatomically
accurate features. Lastly, the DICOM dataset acquired by the CT and the TRUS will
be co-registered with the 3D dataset acquired from the Timepix.
The set-up is composed of two systems:
1. TRUS stepper stager (supplied by SGCC) mounted on the plastic stager de-
signed at CMRP to accommodate the gel phantom. The TRUS is inserted into
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Figure 5.29 Photo of the experimental set-up for measurements in gel phantom.
the rectal cavity, allowing space for placement of the brachytherapy needle grid
template;
2. On the backside of the phantom is located a motorised stepper motor with
the Timepix/FITPix/pinhole system mounted upside down to sit flush with the
superior surface of the phantom. The position of the Timepix is recorded with
respect to the TRUS probe for post-processing and geometrical reconstruction.
The entire system as shown in Figure 5.30 is placed on the CT patient couch and
scanned after seed implantation for direct comparison. A full three-dimensional co-
registration with the ultrasound dataset will further allow for full volumetric and
dosimetric analysis using BrachyView. These measurements were performed with
the assistance of the Prostate Cancer Institute at St George Cancer Care Centre.
5.8 Software Development
A GUI was developed in MATLAB to assist in the calculation of the seed coor-
dinates in 3D from projection images in three-dimensions. This was developed in
MATLAB’s built-in GUIDE (GUI Development Environment) framework. The end-
goal of this part of the project is to develop a Java-based plugin for incorporation into
the Pixelman software.
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Figure 5.30 Screenshot showing the BrachyView software developed to handle Timepix data
and calculate coordinates in 3D.
Currently, the GUI exists as a post-processing procedure for analysis of data acquired
prior to loading the program. Once the data is loaded as a matrix of counts, the
user examines the data and manually selects the seed projections and inputs their
corresponding X and Y coordinates. The GUI converts these values to mm to obtain
the position of each individual seed in three dimensions. This procedure is repeated
seed by seed for the user to analyse externally.
5.9 Summary & Conclusion
In-phantom measurements have been performed to show the capabilities of BrachyView
to resolve the implant positions within 1-2 mm of expected positions in a multi-seed
scenario. Seed localisation can be performed in real-time allowing for doctors to ad-
just accordingly with sub-mm accuracy. While 20 active seeds are still short of the
full clinical implant (between 60-120 active sources), the high resolution capabili-
ties of the in-body gamma camera across multiple projections shows that it is able
to resolve sources even at the maximal distance of 50-60 mm away from the pinhole
Experimental BrachyView Feasibility Study 128
collimator.
The use of a single pinhole-detector set-up requires a motor stepper system which
introduces systematic errors in positioning of the detector and accurate localisation
of the pinhole coordinates. The actual position of the pinhole may differ from the
assumed position, which manifests an error in the reconstructed positions. With the
next stage of development towards a fully functional multiple chip assembly, the need
for an alignment and moving apparatus would be obviated, therefore introducing a
well-defined, shared rigid coordinate system as well as removing the uncertainty in
pinhole location relative to this system.
The introduction of the BrachyView imaging system into the prostate LDR PPB pro-
cedure will provide a valuable tool for ITDP, as this study has shown its capability to
resolve and localise seed positions within 1-2mm of expected positions in real-time.
By informing physicians of this data, adjustments and improvements can be made on
the PPB implant as it occurs, therefore improving patient outcomes. Furthermore, its
use as a post-implant dosimetric tool has been verified by comparison with CT scans,
showing a high accuracy without the need for external imaging equipment.
Chapter 6
Computed Tomography in Prostate
Brachytherapy
CT imaging of the prostate brachytherapy implant is an essential part of the PPB
procedure and is used as a means of post-implant dosimetry quality assurance. It
is proposed that by using the Timepix detector, BrachyView can be used as a novel
in-body imaging plane for use in CT reconstruction of the prostate implant. This
chapter describes the feasibility test of a phantom study using tomographic methods
for 3D reconstruction of LDR seed position.
6.1 Timepix in Tomography
The Medipix family of detectors has had extensive application in the use of many
tomographic studies, in particular for entomological and botanical studies. It is par-
ticularly suited for measuring attenuation profiles, and so when combined with the
rotational projection images in tomographic set-ups, an accurate 3D reconstruction
can be obtained. The usefulness of Timepix in measuring an attenuation profile is
highlighted by the work of Jakubek (10).
Medipix detectors equipped with an appropriate sensor chip (Si for small or light
objects, e.g. soft tissue, GaAs or CdTe for larger or heavier objects) are well-suited
for CT measurements. The extremely high resolution pixel-by-pixel measurements
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Figure 6.1 Concept of pixel-by-pixel attenuation measurements in Medipix necessary for
tomographic reconstruction of sample being imaged. The attenuation profile (indicated by
the red line and t(x)) for each slice can be calibrated to a corresponding thickness of the
sample.
can be used for the measurement of intensity profiles corresponding to attenuation
through the sample. The measured projections are linearised as a per pixel signal-to-
equivalent-thickness calibration. The number of counts per pixel can be calibrated
directly to a thickness measurement of the physical sample by appropriate methods
(this is often done by a beam-hardening correction, or ’linearized signal to equivalent
thickness’ as outlined by Vavrik and Jakubek (70)). The concept of a pixel-by-pixel
measurement of a sample is shown in Figure 6.1.
6.2 CT Measurements in PPB
Once the brachytherapy implant has been completed, the patient is taken to the CT
room located elsewhere in the hospital. This multi-step procedure allows for a post-
implant dosimetric assessment, but does not allow for intraoperative adjustments of
the implant.
However, it is proposed that by using BrachyView, already in place in the rectum,
a simple external X-ray source such as a C-arm X-ray unit or similar, can be used
to provide the incident X-rays. By rotating the X-ray source around the patient’s
prostate, a set of projection images corresponding to attenuation profiles can be ob-
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Figure 6.2 Concept for using BrachyView as an in-body imaging plane for tomography mea-
surements. Image not to scale.
tained and used for tomographic reconstruction.
Standard CT reconstruction is done by means of a mathematical function known as
the Radon transform (71). A Radon transform in two dimensions is the transform
consisting of the integral of a function over a series of straight lines. In terms of a
tomographic measurement, this consists of attenuation data across a range of angles
θ. This information is necessary for any tomographic reconstruction.
Mathematically, the Radon theory states that any unknown function can be recon-
structed from an infinite set of its projections. Therefore, if a function f represents
some unknown density of a material, then the Radon transform represents the scatter-
ing data obtained as the output of a tomographic scan. An inverse Radon transform
can then be performed to obtain an image reconstruction. This is the underlying
principle allowing tomographic reconstruction to occur.
The visual representation of a Radon transform is commonly known as a sinogram
due to its graphical appearance resembling a series of blurred, superimposed sine
waves of varying amplitude and phase. The columns of R contain the attenuation
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Figure 6.3 Concept of the Radon transform. Image courtesy of Hayden (16).
data for each angle in the entire dataset of projections used.
A typical tomographic reconstruction consists of the following steps:
1. Measure attenuation profile using an external X-ray source and imaging plane;
2. Repeat measurement of attenuation profiles around patient with projection data
taken at every angle iteration;
3. Perform a radon transform of the data to obtain sinograms;
4. Backprojection techniques of density reconstruction (i.e. attain tomographic
slices).
Consider for example the mathematical body the Shepp-Logan phantom. As illus-
trated in Figure 6.4 (72), an accurate representation of the original phantom can be
reconstructed from the Radon transform. This is known as a filtered back-projection
(FBP) technique (71), whereby every point in the projection image is back-projected
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Figure 6.4 Left: Mathematical phantom used to illustrate principle of Radon transformation.
Centre: Radon transform of the Shepp-Logan phantom over 180◦ of projections. Right: The
inverse Radon transform of the sinogram in centre.
along a line for all θ. When enough back-projection angles are performed, a recon-
struction of the density within the sample can be accurately determined.
In order to obtain the images necessary for tomographic reconstruction, the set-up
at the Institute of Experimental and Applied Physics (Czech Technical University in
Prague) is shown in Figure 6.5.
For this study, a collection of dummy seeds were used. As in the pinhole study,
these are Model 6711 I-125 seeds (supplied by IsoAid, LLC), but inactive. There-
fore, no dose considerations are made when taking these tomographic measurements.
However, due to the pixel-to-pixel thresholding capabilities of the Timepix, it is pro-
posed that additional dose from the active sources can be filtered out through post-
processing, or even during measurements, as a way of subtracting background as
described in the pinhole study. Furthermore, subtraction of background can be done
spectroscopically by selection of the 22-35 keV energy window in order to block
counts from the seeds themselves.
Rather than rotating the external X-ray source around the sample as is typical in a
CT scan, the sample (in this case the PMMA phantom with implanted dummy seeds)
is attached to a rotation table and rotated relative to the stationary imaging plane.
This provides us with the rotation projection images required. Note that this does not
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Figure 6.5 Experimental set-up of tomographic measurements using single Timepix device
available at the time.
Figure 6.6 Photo of dummy brachytherapy sources used in tomographic measurements.
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truly correspond to the patient/external X-ray source set-up, which would involve a
stationary detector plane relative to rotational motion of the X-ray source. However,
for the purposes of this thesis, a preliminary evaluation of the tomographic applica-
tion of BrachyView is all that is required. Future work will investigate this process
further, through the use of tomographic laminography techniques for example.
The process for obtaining a tomographic reconstruction is as follows:
1. Align the sample with the detector plane, ensuring it is horizontally parallel
relative to the pixel plane;
2. Minimise magnification factor by minimising source-object and object-detector
distances;
3. Obtain a minimum of 181 projection images. The extra angle is to serve as a
back-up in case artifacts appear in the first image, which are not uncommon;
4. Perform a beam hardening correction for the raw data;
5. Check that the axis of rotation is in the centre of the Timepix image; for a
frame of 256×256 pixels, this corresponds to column 128 of the detector. If
not, some padding of the images can be used to correct this (typically as a
shift of a few pixels). Padding refers to an artificial correction whereby a small
number of pixel columns is interpolated into the frame to shift the experimental
image to the required axis of rotation (i.e. around column 128).
6. Create sinograms;
7. Perform tomographic reconstruction.
The tomographic reconstruction can be performed by filtered back projection as dis-
cussed above. To evaluate this technique, the MATLAB function iradon (inverse
radon) is used.
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Figure 6.7 Comparing filtered and unfiltered backprojection images on the standard Shepp-
Logan phantom in MATLAB.
6.2.1 Inverse Radon Transform
Given a set of projection data presented as two-dimensional sinograms, the inverse
radon function is able to reconstruct the image. It utilises the filtered back-projection
algorithm, where the filter is designed to work directly in the frequency domain and
then multiplied by the fast Fourier transform (FFT) of the projections. The pro-
jections are zero-padded to a power of 2 before filtering to prevent spatial domain
aliasing and to speed up the FFT.
The reconstructed image in tomography measurements is not a standard image as
shown in Figure 6.7, since the projection images are based on the attenuation of
X-ray radiation incident on the physical sample. In this case, the image being recon-
structed is actually a cross-sectional slice through the physical sample (i.e. the slices
necessary for 3D reconstruction). The thickness of this slice corresponds to the voxel
space as defined by the physical parameters of the detector and the reconstruction al-
gorithm itself.
An important fact of the inverse radon reconstruction is that it reconstructs an image
based on parallel beam projections through the sample. In parallel beam geometry,
each projection image is formed by combining a set of line integrals through an image
at a specific angle.
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Figure 6.3 illustrates how parallel beam geometry is applied in tomographic mea-
surements. Note that there is an equal number of n emitters and n detectors. While
this is the ideal case, it can be successfully approximated by using a point source at a
large enough distance. Each detector measures the radiation emitted from its corre-
sponding emitter. The attenuation gives a measure of the integrated density or mass
of the object. This corresponds to the line integral that is calculated in the Radon
transform.
The filtered backprojection algorithm forms an approximation to the image I based
on the projection in the columns of R (the Radon transform). By increasing the
number of projections used (θ), a more accurate reconstruction can be obtained.
In some cases, noise can be present in the projections. Many windowed filters are
available in inverse radon. However, another common method of working with noisy
data is by using iterative reconstructive algorithms.
6.2.2 Iterative Reconstruction
Filtered back projection is known as an analytic form of tomographic reconstruc-
tion. It yields fast computation thanks to the fast fourier transformation techniques
employed, yet it is valid for an infinite number of projections and noiseless data.
Furthermore, it is known that analytic models cannot involve more complex physical
models.
A viable alternative to an analytic method is an iterative method, which is based on
repetitive improvements of the reconstructed image to achieve maximum correspon-
dence to its computed projections obtained from measurement.
Iterative algorithms have several advantages over analytic methods such as FBP:
1. The computation time at each iteration cost is approximately the same time as
two FBPs;
2. Convergence is fast and stable even in the domain of a small number of pro-
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jections (limited data) and noisy data (bad data);
3. Can handle general geometries such as varying pixel and voxel size, non-
uniform voxel shapes, non-uniform pixel shapes, missing projection angles,
missing angles etc;
4. Can incorporate increasingly complex physics models such as beam hardening
effects, scattering and phase shift effects.
In general, iterative algorithms repeat these steps:
1. Compute numeric projections of current reconstructed image (first iteration);
2. Compare these projections with measured data;
3. Modify current reconstruction to obtain the next iteration;
4. Repeat from step 1.
An example of a common iterative algorithm is shown in Figure 6.8. From left
to right on the top, a sinogram is shown and its (unfiltered) backprojection. This
backprojection undergoes its own projection transformation and is then compared
with the original data. Going from left to right on the bottom shows the iteration In+1
and how much clearer the image is compared to In. Each iteration is an improvement
on the previous reconstructed image. The process is explained in detail in Table 6.2.2.
The iterative process converges to a solution when the change between successive
iterations is negligible.
A more specific form of expectation maximisation is known as ordered subsets (OSEM).
The most CPU intensive task when calculating tomographic reconstruction is the
computation of the projection (P) and the back projection (BP). P and BP complex-
ity is linearly dependent on the number of projections used, and not all the projec-
tions have to be used in every step. The iteration is hence divided into subiterations,
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1. Measure projections and obtain sinogram D
2. Compute back projection of data to obtain the first iteration I1 = BP (D)
3. Make projections of current iteration P (In)
4. Compare with measured data to create a ’ratio’ C = D/P (In)
5. Compute back projection of the correction coefficients BP (C)
6. Apply correction to current iteration and obtain new iteration In+1 = In ·BP (C)
7. Repeat from 3.
Table 6.1
The process of iterative image reconstruction detailing the contents of Figure 6.8. (17)
Figure 6.8 Example of iterative reconstruction. Process goes from left to right on top and
then on bottom. (17; 18)
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whereby each subiteration uses just a subset of all the projections. Using OSEM, the
comparison between P and BP, and subsequent update is based on a smaller number
of the projections (i.e. a subset) for each iteration. Therefore, the algorithm progres-
sively uses other projections in each further iteration (or sub-iteration) leading to a
much faster computation time. (73).
6.3 Phantom Measurements
A phantom study was designed to perform tomographic reconstruction of a prostate
phantom with implanted dummy Model 6711 I-125 seeds, using an external X-ray
source and a 60×60×40 mm3 PMMA cube containing drilled channels to mimic the
brachytherapy implant template. To simulate the rotation of an external C-arm X-
ray source, the sample is rotated relative to the X-ray source. Data is taken at one
projection per angle covering 0-180.
Using iterative methods such as OSEM (ordered subset expectation maximisation),
the phantom with implanted seeds is reconstructed from limited views and the re-
constructed images are evaluated based on number of subsets used per projection set
(minimum of three ordered subsets). A complete dataset of 180 projection images is
used as a way of evaluating the reconstruction algorithm before testing limited angles
and incomplete field of view reconstructions.
By using an external X-ray source such as a C-arm, the projection images necessary
for tomographic reconstruction can be obtained using the Timepix as the imaging
plane. However, as an in-body imaging device, the system has to overcome problems
associated with having an imaging plane smaller than the object being reconstructed.
The experimental set-up is as shown in 6.5, with the PMMA phantom consisting of
a matrix of 5×5 holes with 10 mm between each. For an evaluation of tomographic
reconstruction capabilities of the BrachyView system, two areas of reconstruction
are considered.
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Figure 6.9 Eight seeds placed in a single plane so as to be viewed by single Medipix in
rotational motion for tomographic reconstruction
Eight seeds are arranged in a two-square formation in the same plane so as to cover
the entire volume of the phantom. The placement of the seeds in locations A1, A5,
B2, B4, D2, D4, E1, and E5 were specifically chosen for this purpose. This can be
considered as defining two ’squares’:
1. Inner square consisting of seeds in locations B3, B4, D2 and D4 in locations
closest to the patient’s intraprostatic urethra;
2. Outer square consisting of seeds in locations A1, A5, E1 and E5 in locations at
the outer edge of the patient’s prostate, since a typical gland is no larger than
50 mm3.
Their locations are shown in Figure 6.9.
By taking projection images of these seeds in the phantom, the inner and outer
squares mean that we have covered all possible cases of seed position in the tomo-
graphic reconstruction. Since the reconstruction function can be repeated as a simple
superposition of the sinograms, the simplest case can simply be extrapolated out to
draw a conclusion for more complicated cases involving multiple seed scenarios.
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Figure 6.10 Comparison between standard filtered back projection (inverse radon) and
OSEM iterative reconstruction using 3 subsets. nIt is the number of iterations and ai is
the angle iteration, i.e. 10◦, 5◦, and 2◦.
6.3.1 Matlab Simulations
As introduced in Section 6.2, the Shepp-Logan phantom is a mathematical body built
into MATLAB that is commonly used for testing reconstruction algorithms (see Fig-
ure 6.7). It was developed as a purely theoretical tool to evaluate reconstructions
without a need for experimental considerations. It was designed by Shepp and Lo-
gan (72) as a simulated head phantom. To demonstrate the principle of an iterative
reconstruction using an OSEM approach, the algorithm is tested on a Shepp-Logan
phantom, as well as other simplified mathematical bodies. The results for the Shepp-
Logan phantom for different angular iterations (ai) are shown in Figure 6.10.
A mathematical evaluation of the reconstruction algorithm is performed to evaluate
the presence of offset or distortion due to the incomplete sinogram datasets. For
example, using a matrix corresponding to 1000×1000 elements, used to approximate
the volume of the PMMA phantom (where one element corresponds to one voxel
size in the reconstruction; corresponding to approximately 1000×55 µm pixels in a
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Figure 6.11 Blue circles indicate the location of simulated ’seeds’ in Matlab.
60 mm3 phantom).
By drawing a circle in the matrix equal to value 1, a high contrast density material
is simulated corresponding to the presence of the high density Ti seed in the PMMA
phantom. Figure 6.11 shows the location of simulated seeds.
Two-dimensional intensity profiles can be obtained by performing a Radon transform
of this matrix. Therefore, a mathematical evaluation of the reconstruction algorithm
can be performed.
6.4 Tomography Study
Before performing the tomographic reconstruction using data from the BrachyView
system, a preliminary full CT-scan of a gel phantom was performed.
Using a mixture of commercially available tissue-equivalent gelatin, a number of
dummy seeds were implanted into the gel volume through the brachytherapy tem-
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Figure 6.12 Preliminary experience with CT reconstruction of a dummy seed implant in gel
phantom.
plate with the assistance of the St George Cancer Care Centre, who provided advice
on the procedure and the handling techniques for LDR procedures. This allowed us
to gain a deeper insight into the requirements of BrachyView for final application in
a clinical context.
The following results shown in Figure 6.12 were obtained, allowing for a qualitative
analysis showing that the seeds had a tendency to blur into one another, due to overlap
in the tomographic reconstruction from their relatively small size compared to the
CT slice. The width of the CT slice and therefore accuracy in source localisation
is constrained by patient dose, therefore providing the motivation behind evaluating
BrachyView’s application as a high-resolution, in-body, intraoperative CT system.
Following this preliminary study, the application of Timepix detectors used in BrachyView
for tomographic reconstruction was tested. While Medipix and Timepix have been
successfully used in CT studies for plant and insect studies, in BrachyView, the ob-
ject being imaged is much larger than the imaging plane available, presenting the
novel problem of reconstructing from limited angles and limited field of view, as
discussed in Section 6.2.2.
Preliminary results showing successful tomographic reconstruction have been ob-
tained. The algorithm used was OSEM, using 3 subsets and 1 iteration for each slice.
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Figure 6.13 Projection images keeping a single dummy seed within the field of view of the
phantom and the resulting 3D reconstruction.
Due to the imaging capabilities of the high-resolution Timepix detector, accurate 3D
reconstructions of seed implant structure can be seen as in the following figures.
These results were obtained by keeping the dummy seed and the central axis of rota-
tion completely within the field of view of the single Timepix. By shifting the single
dummy seed away from the central axis of rotation, such that rotation occurs outside
the field of view, a so-called ’off-axis’ reconstruction can be obtained as shown in
Figure 6.14.
Once this 3D reconstruction was confirmed, a multiple seed phantom study was per-
formed for seeds located outside the central field of view of the single Timepix de-
tector as shown in Figure 6.14. A full 3D CT reconstruction was obtained as shown
in Figure 6.15.
Preliminary quantitative analysis shows the seeds within 2-5 mm of expected po-
sitions. Note the presence of a single thin sinusoidal shape in the sinogram. This
corresponds to the inclusion of a thin copper wire in the centre of the phantom as a
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Figure 6.14 The same process is repeated for a single seed, but this time deliberately putting
the seed off-axis such that the sinogram obtained is incomplete.
reference marker for calculating of expected positions.
The full 3D reconstruction is shown in Figure 6.16.
By comparing with the expected positions of the seeds based on their known posi-
tions in the phantom, a comparison can be obtained as shown in Figure 6.17. The
numerical results are shown in Table 6.2. For this method, a minimum discrepancy
of 0.6 mm was found with a maximum of 5 mm. For seeds more than 3 mm from
expected positions, these present a dosimetric issue for the patient. Therefore, some
offset correction or systematic errors must be addressed as discussed in Section 6.5.
However, it is evident that some agreement between expected and calculated posi-
tions is obtained.
The results show that for seeds near the central axis of rotation, there is close agree-
ment with that of the expected positions. However, as the reconstruction moves
farther from the centre, a larger discrepancy occurs as is expected. This is due to the
low amount of density information obtained as a consequence of the partial field of
view problem. As the seeds on the outer perimeter move rapidly in and out of the
field of view, as demonstrated by the sinograms in Figure 6.15. We only see a fairly
narrow range of projections due to the small size of the imaging plane relative to the
phantom, hence the partial sinogram. This results in the inner seeds getting more
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Figure 6.15 For eight seeds implanted, the Radon transform resembles a sinusoidal shape
less and less as the seeds farthest from the axis of rotation move rapidly out of the field of
view.
Figure 6.16 Three dimensional reconstruction of the eight dummy seeds in the phantom.
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Figure 6.17 Experimental results from OSEM reconstructed data, compared to expected po-
sitions in the phantom.
projections than the outer seeds hence appearing brighter in the reconstruction.
Furthermore, an effect as described by Brunetti and Golosio (74), known as the
screening or shadowing effect is evident in the tomographic slices containing the
eight seeds (see the internal structure of the seeds as shown in Figure 6.15). The
screening effect is overcome by a morphological technique based on computer graph-
ics. However, this work is beyond the scope of this thesis. The resulting elongated
effect is modelled in MATLAB by obtaining 2D intensity distributions, performing
Seed Position X coordinate(mm) Y coordinate (mm)
B2 -8.905 [1.095] -11.49 [1.49]
D2 13.425 [3.425] -8.96 [1.04]
D4 11.61 [1.61] 12.93 [2.93]
B4 -10.72 [0.72] 12.16 [2.16]
E5 21.18 [1.18] 23.765 [3.765]
A5 -24.69 [4.69] 23.655 [3.655]
A1 -20.675 [0.675] -25.405 [5.405]
E1 24.095 [4.095] -18.64 [1.36]
Table 6.2
Experimental results showing reconstructed coordinates and the difference with the expected
values. Differences are shown in square brackets.
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Radon transforms and testing the OSEM algorithm for an analytic model to correct
for this offset.
Lastly, by increasing the step size between angles used in CT reconstruction, CT slice
image quality can be assessed for the feasibility of using a limited angle approach.
The angle iteration is increased as shown in Figure 6.18. However, it appears that
the resulting reconstruction is degraded in quality and in fact it becomes almost im-
possible to localise the sources as the angle iteration (ai) increases past 5o. The
quantitative analysis is shown in Figure 6.19.
As the angle iteration increases, the accuracy in determining the exact centre of mass
in each seed in the tomographic slice degrades correspondingly. This effect worsens
significantly at the outer edges of the reconstruction, i.e. for seeds further from
the centre of rotation. This issue should be addressed in future work, by further
refinement of the reconstruction algorithm to also incorporate a priori knowledge of
seed structure. However, to better investigate any distortion introduced by the OSEM
algorithm, simulated work in MATLAB is performed as described in the following
section.
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Figure 6.18 Reconstructions showing Radon transformations of varying angular iterations to
evaluate the use of partial view tomographic reconstruction.
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Figure 6.19 Reconstructed positions in tomographic slice of dummy seeds.
6.4.1 Matlab Simulations
In order to correct for the possibility of offset and elongated distortion error, the
mathematical simulation yields results as shown in Figure 6.20.
By examining the data from this mathematical simulation, an offset relation can be
obtained as a function of radial distance from the centre. For a simpler case, consider
the case of 16 circular elements with a diameter of 8 elements (i.e. 0.4 mm, assuming
each single element corresponds to a single voxel of 0.055 mm as in the detector
plane). In Figure 6.21, the 16 seeds are located at positions corresponding to those
shown in Table 6.3.
From this data, the following sinogram is obtained by the Radon transform.
The reconstructed slice is obtained through OSEM using s=6, and nIt=1.
It is noted that some distortion is evident in the reconstructed shape such that the
original circular elements resemble elliptical shapes. The extent of the centre of
mass offset is calculated as a function of radial distance from the centre as shown in
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Figure 6.20 These are the results compared to expected positions for a simulated mathemat-
ical body.
Number Position in phantom
1 A1
2 A5
3 A3
4 B2
5 B4
6 b2.5
7 b3.5
8 C1.5
9 C4.5
10 c2.5
11 c3.5
12 D2
13 D4
14 d3
15 E1
16 E5
Table 6.3 Numbers and their corresponding position ’in phantom’.
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Figure 6.21 Matrix showing 16 seeds simulated as circular point sources.
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Figure 6.22 Sinogram of the 16 seeds as shown in Figure 6.21
Figure 6.23 Results from OSEM reconstruction compared to original positions
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Figure 6.24 Offset factor calculation as a function of distance from centre of reconstruction.
Figure 6.24.
However, when this correction factor was applied to the experimental data, the re-
sulting positions were not improved when compared to the expected positions.
6.5 Summary & Conclusion
The BrachyView system is a transrectal, ultra-functional imaging probe developed
for use in treatment planning for permanent prostate brachytherapy. It is capa-
ble of performing pre-planning, intra-operative dynamic dosimetry and post-implant
dosimetry. This proof of concept study indicates that BrachyView is capable of re-
solving LDR I-125 seeds accurately for post-implant.
This proof of concept study shows the viability of applying a novel design of the
Timepix detector as an in-body imaging plane for tomographic reconstruction of I-
125 PPB implants.
Preliminary quantitative analysis has been performed to localise sources within 2-5
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mm of expected positions. However, due to systematic errors within the reconstruc-
tion algorithm, this discrepancy is yet to be addressed in future work. Systematic
errors as a result of experimental set-up (e.g. axis of rotation) and assumptions made
regarding other geometrical factors were not accounted for.
Furthermore, the so-called screening effect of seeds at a larger radial distance from
the centre results in the reconstruction algorithm misplacing density at some offset.
A continual refinement of the OSEM reconstruction algorithm is proposed with in-
corporation of a priori knowledge of the implanted I-125 seeds.
With BrachyView being used in the operating theatre, the system will ultimately be
an ultra-functional imaging probe, able to perform pre-planning, intraoperative treat-
ment planning, as well as a post-implant dosimetry check all within one device. By
streamlining the entire brachytherapy implant procedure into a single room proce-
dure, BrachyView will enable the physicians to perform more realistic and accurate
checks in real-time, and also provide a more cost-effective solution to treatment plan-
ning for permanent prostate brachytherapy.
Chapter 7
Tissue Diagnostic X-Ray Imaging
This chapter presents the experimental work performed on a tissue-equivalent med-
ical gel phantom, for testing the application of the Timepix detector in X-ray trans-
mission imaging of soft tissue; namely the prostate gland and surrounding anatomical
structures. The Timepix detector has unlimited dynamic contrast and has potential
for use in soft tissue diagnostic imaging. By using materials of similar electron
density, this feasibility study highlights BrachyView’s capability for high-contrast
imaging. The system is evaluated for organ delineation and even tumour diagnosis.
By showing that BrachyView can be used for various imaging applications, it will al-
low for a multi-modality treatment planning system that provides more accurate and
real-time dosimetry and therefore better patient outcomes in sparing critical struc-
tures from incorrectly placed dose.
7.1 Use of Timepix in X-Ray Diagnostic Imaging and
Phantom Measurements
For accurate dosimetry in prostate brachytherapy implant procedures, accurate vol-
umetry of the prostate combined with seed positioning in real-time is ideal. Cur-
rently, the preference of TRUS imaging over CT for volumetric studies has been
dictated by the poor resolution of soft tissue typical of conventional CT imaging.
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The Timepix has unique imaging properties and fast readout time, allowing it to be
used for the identification of materials of varying density and elemental composition.
The high resolution and high contrast imaging properties of the Timepix suggest that
it is an appropriate detector for use in soft tissue imaging applications.
It has been proven that for thin samples (0.3-0.5 cm) of plexiglass coupled with water,
x-ray transmission imaging is effective for distinguishing materials of similar density
as shown by Jakubek (75). Based on X-ray transmission information obtained by the
Timepix detectors, the internal structure of the prostate gland and its surrounding
structures can therefore be delineated and incorporated into patient treatment plans.
Furthermore, the Timepix detector has no noise and an unlimited dynamic range,
making it perfectly suited for applications in biological X-ray imaging.
The aim of this study was to investigate whether Timepix detectors can be used to
identify thicknesses of material relevant to a medical and clinical context. By ap-
plying Timepix in such X-ray transmission imaging, the applicability of BrachyView
for soft tissue diagnostic imaging can be assessed, therefore adding another imaging
modality to the in-body imaging probe.
For this study, a tissue-equivalent medical phantom was used. The phantom is pic-
tured in Figure 7.1 and was developed by CIRS (Computer Imaging Reference Sys-
tems) as a disposable phantom specifically designed for training procedures which
involve scanning the prostate by TRUS. It consists of clear acrylic, urethane and Zer-
dine, which is described as a ”durable and accurate tissue-mimicking material...[that]
accurately simulates the ultrasound characteristics of human liver tissue” (76).
Two main scenarios were investigated using this tissue-equivalent phantom.
Firstly, using the BrachyView triple detector prototype as shown in Figure 3.2, an
assessment of the Timepix’s ability to distinguish soft tissue structures is performed.
In the experimental set-up, the triple Timepix detector is wall-mounted adjacent to
the phantom such that the prostate is aligned within the field of view. The sensor on
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Figure 7.1 Schematic showing prostate phantom used for ultrasound imaging training pur-
poses. Image courtesy of Computerised Imaging Reference Systems (CIRS).
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Figure 7.2 Experimental set-up to evaluate use of TimePix in soft tissue diagnostic imaging.
this triple detector was the standard 300 µm thick Si.
Note that while the proposed set-up for the actual prostate implant procedure calls
for the use of a transrectal probe, this study was performed out of the rectal cavity
due to the physical limitations of the X-ray cabinet set-up. However, accounting
for the spherical nature of the prostate and average rectal wall-prostate distance of
approximately 5-10 mm, the measurements can be considered equivalent to a true
transrectal set-up, as far as our purposes go.
Based on previous studies for optimisation of X-ray voltage (77), images were ac-
quired at 50 kV at a power of 7.5 W. The phantom is mounted as shown in Figure
7.2 and scanned laterally with images obtained at 1 mm increments to determine the
location of the prostate boundary and any other features present, such as the intrapro-
static urethra, or the seminal vesicles as indicated by Figure 7.1.
Once the prostate boundary was identified, additional thicknesses of tissue-equivalent
plastic were introduced into the field of view of the triple detector, allowing an evalu-
ation of the Timepix’s ability to distinguish varying thicknesses of material of similar
elemental composition.
For this experiment, 2 mm thick slabs of PET plastic (polyethylene terephthalate with
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Figure 7.3 Schematic showing the tissue-equivalent prostate phantom with stacked plastic
layers (configuration shown on right) stuck on the side. These are placed in direct field of
view of the Timepix detectors. For the 300 µm thick sensor, each plastic layer used was 2
mm thick. For the 1 mm sensor, each plastic layer was 0.2 mm.
a density of 1.38 g/cm3) were stacked atop one another to create a step sequence of
thicknesses corresponding to 2, 4, 6 and 8 mm total thickness. These plastic slabs
were introduced into the field of view such regions of interest within both the prostate
region and the surrounding ’tissue’ (or gel) were located behind each thickness step
accordingly.
Standard transmission X-ray images are acquired for a total of 20 minutes. This time
was selected to provide a satisfactory number of events per pixel for us to establish
a suitable signal-to-noise ratio. The quantification of the Timepix’s resolving and
contrast power is performed by a standard SNR equation shown below:
SNR =
|µ1 − µ2|√
σ21 + σ
2
2
(7.1)
where µ is the mean value, and σ is the standard deviation in each respective region
of interest.
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After this measurement was completed, an additional study was performed utilising
a thicker sensor to maximise our detection efficiency and thereby reducing the acqui-
sition time and increasing our imaging contrast capabilities. The triple detector was
replaced with a single Si sensor of 1 mm thickness and the X-ray tube brought as
close as possible to the phantom surface to maximise beam intensity. Furthermore,
instead of using 2 mm thick slabs of tissue-equivalent plastic, much thinner slices of
0.2 mm were used to push the limits of the detector evaluation.
The SNR of the system was evaluated as a function of exposure time, normalised
as number of photons/pixel in order for us to establish a feasible operating time for
brachytherapy practitioners interested in obtaining soft tissue diagnostic images of a
patient’s prostate using the BrachyView system.
For the time being, no incorporation of actual tissue samples has been considered
nor the amount of body fat and other surrounding tissue such as bone and other
internal organs. However, considering that our system only had a maximum output
of approximately 9W and when compared with kW clinical systems, this feasibility
study serves as a primarily qualitative evaluation of the applicability of Timepix for
soft tissue diagnostic imaging.
7.2 X-ray Transmission Imaging with Gel Phantom
Once a suitable signal to thickness calibration was performed (also referred to as
beam hardening calibration), the images obtained are evaluated for mean values and
standard deviation in each respective region of interest; i.e. for regions in the images
corresponding to the prostate tissue and the surrounding soft tissue. Each region is
evaluated behind the PET layers and without any additional plastic thickness. The
SNR can therefore be evaluated as a function of thickness, based on the thicknesses
of tissue-equivalent plastic introduced.
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Figure 7.4 Example of images obtained on triple Timepix detector. The prostate region
can be delineated as the bright circular shape across all three detectors, with the lowermost
detector only seeing the distal edge of the prostate boundary. From left to right, the boundary
of each plastic stack layer can be seen as they are added incrementally. i.e. one plastic region
on the (a) up to four plastic stacks as shown in (d). Each step thickness of additional PE
plastic represents a change of 2 mm additional plastic as shown in white (d).
7.2.1 300 µm Si Sensor
Figures 7.4 and 7.5 show the results obtained for the 300 µm silicon sensor chip,
arranged in a linear 3×1 triple detector configuration. The X-ray energy used was
50 kV, with an exposure time of 1200 s, equivalent to approximately 15,000 incident
photons per pixel. Successive layers of PET plastic were stacked on top of each
other within the field of view and the SNR in each region evaluated with respect to
the transmission image obtained with no plastic material present. Each additional
layer of plastic was 2 mm thick as described in Section 7.1.
Initial inspection shows a clear delineation of the prostate boundary with respect
to the soft gel surroundings, as indicated by the white circular mass in Figure 7.4,
allowing the SNR to be calculated for two regions of interest: one region inside the
prostate, and the other in the surrounding tissue, as shown in Figure 7.5.
Tissue Diagnostic X-Ray Imaging 164
Figure 7.5 SNR as calculated for the region in the prostate and also in the area surrounding
the prostate showing the expected SNR as a function of thickness change.
Furthermore, a theoretical SNR calculation is performed based on an assumed Pois-
son noise distribution as shown in grey. This was done by comparing the experimen-
tally obtained standard deviation of each region of interest with the expected square
root value typically associated with a general Poisson noise distribution, as shown in
Equation 7.1.
The experimentally-measured SNR was approximately equal to 1.5-3 for non-prostate
tissue and 2.5-4.5 for prostate tissue, which are lower than the range of values pre-
dicted by the Poissonian distribution of approximately 3.5-8; this can be attributed
to fluctuations in the output power of the X-ray source, and possible temperature
dependence of the detectors leading to statistical fluctuations in the acquired sig-
nal. Despite this, the Timepix detector is able to satisfactorily differentiate between
prostate and non-prostate tissue for most ranges of thickness change.
7.2.2 1mm Si Sensor
The results shown in Figure 7.4 show the applicability of a standard 300 µm thick
Si sensor in identifying anatomical features within a tissue-equivalent prostate phan-
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Figure 7.6 Images of the prostate boundary obtained by single 1 mm Si sensor. The prostate
region appears darker in the beam hardening corrected data as it is of lower density than
the surrounding tissue, and therefore appears as a lower equivalent thickness from high sig-
nal (i.e. raw counts). The red spectra are count bins as calibrated for thickness and beam
hardening correction. The two peaks show a clear delineation between prostate tissue and
surrounding tissue allowing a diagnostic analysis of tissue thickness and boundaries.
tom. The further possibilities of BrachyView are evaluated by performing imaging
characterisation of a 1 mm thick Si sensor on the same phantom configuration. A
thicker sensor chip means higher efficiency, and therefore higher statistics within a
shorter time, allowing for more accurate imaging performance.
By using a single detector and even thinner samples of plastic (0.2 mm) the contrast
of such a detector evaluated as a signal to noise ratio as a function of exposure time
can be evaluated as discussed previously. By decreasing the X-ray source-phantom
distance to 10 mm, and increasing tube output to its maximum capacity (at 90 kV
and 110 µA), maximum beam intensity can be achieved.
The images obtained once corrected for beam hardening are shown in Figure 7.6.
The exposure time is normalised to average number of photons per pixel as detected
Tissue Diagnostic X-Ray Imaging 166
Figure 7.7 SNR for thickness change of 0.2mm within two different regions of interest in the
imaging field of view. Exposure time is shown as a function of photons/pixel. By identifying
where the plateau in SNR occurs, the time for this particular system can achieve optimal
imaging characteristics is shown.
by the Timepix sensor, allowing an estimation of the imaging time required to achieve
optimal SNR for thin samples within a change of 0.2 mm as long as the contrast
achieved remains above a certain noise threshold.
Figure 7.7 shows that a certain optimal value of SNR can be achieved within the
first 100,000 photons/pixel whereby increasing exposure time does not lead to any
discernible benefit in imaging power. By comparing this with the typical clinical kW
X-ray source, which is able to achieve much higher intensity and power than our
experimental system, it is clear that a suitable image allowing us to assess soft tissue
anatomical features can be obtained within clinically realistic times. Additional dose
to the patient can therefore be limited accordingly, yet still yielding high contrast for
soft tissue.
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7.3 Summary & Conclusion
For accurate dosimetry in prostate brachytherapy implant procedures, accurate vol-
umetry of the prostate combined with seed positioning in real-time is required. Cur-
rently, the preference of TRUS imaging over CT for volumetric studies has been
dictated by the poor resolution of soft tissue typical of conventional CT imaging.
The Timepix’s unique imaging properties and fast readout time allows it to be used
for the identification of materials of varying density and similar elemental compo-
sition, based on the high resolution and high contrast X-ray transmission imaging
ability of the Timepix detector.
While initial tests with the standard 300 µm thick sensor show positive imaging prop-
erties, the extension of the BrachyView design to utilise a 1 mm thick Si sensor will
provide much greater efficiency, allowing for quicker acquisition times and thereby
reducing the dose to the patient and overall operation time if applied in a clinical con-
text. The evaluation of SNR shows that a plateau in SNR occurs as soon as approx-
imately 100,000 photons/pixel are observed, which for this particular experimental
system was approximately equal to 30 seconds of exposure time. Any additional ex-
posure time does not result in an improvement in SNR, showing that fluctuations in
the system begin to contribute to the noise more than standard Poisson distribution.
BrachyView is being developed as a method for intra-operative dynamic dose plan-
ning as well as a post-implant verification system utilising high-resolution Timepix
detectors. Additionally, the area of diagnostic imaging has also been raised as a
possible application of the Timepix detector. This study shows that we are able to re-
solve the anatomical structures within a medical tissue-equivalent prostate phantom
with an acceptable level of SNR as a function of tissue thickness corresponding to
changes in patient anatomy.
This soft tissue imaging combined with seed position determination indicates that
BrachyView has strong potential as a dynamic dose planning device for use in low
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dose rate prostate brachytherapy procedures. By showing that the same device can be
used for various imaging applications, BrachyView allows for better implant dosime-
try and therefore better patient outcomes in sparing critical structures from excessive
radiation from incorrectly placed seeds.
With the combined ability for diagnostic imaging, monitoring the insertion of seeds
to their initial positions, and post-implant dosimetry checks, BrachyView is an ultra-
functional system allowing for many different imaging modalities within a single
cost-effective and convenient solution.
Future work will involve a repetition of such measurements involving real tissue
samples and consultation with pathological laboratories including prostate lesions,
calcifications and other biological material of note for brachytherapy practitioners.
Chapter 8
Summary of Contributions & Future
Research
A prototype novel in-body imaging device based on pixellated semiconductor detec-
tors has been developed for application in prostate brachytherapy treatments. The
technology used involves a novel application of the Timepix device, as developed
by the Medipix Collaboration at CERN, as well as a lead pinhole collimator system.
The ability of the system to localise radioactive sources in 3D has been demonstrated
through simulation and experimental evaluation. The application of BrachyView in
other imaging modalities has also been proposed, with preliminary feasibility studies
showing possible use in CT imaging, as well as soft tissue diagnostic imaging.
This research leads to the application of a multifunctional rectal probe allowing vol-
umetric studies using both ultrasound and/or X-ray CT imaging. Furthermore, intra-
operative dynamic dose planning based on real-time seed position determination in
the prostate, and post-implant dosimetry based on these locations are presented as an
all-inclusive ’one-stop shop’ procedure.
8.1 Contributions
A review of the current state of prostate brachytherapy treatments was presented,
with particular focus given to the LDR technique as summarised in Chapter 1. The
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development of the Medipix family of detectors has given rise to a high-resolution,
real-time semiconductor detector with application in radiation physics. Due to these
favourable characteristics, the latest generation of Medipix, known as Timepix, was
nominated as a candidate for use in the BrachyView system.
The proposed system involving a novel application of a pinhole collimator required
an analytic evaluation as well as optimisation by simulation work. The novel design
of this device was detailed in Chapter 3, with subsequent characterisation performed
by Monte Carlo methods presented in Chapter 3. It was concluded that a lead colli-
mator was suitable for the purposes of BrachyView.
Several imaging modalities are involved in the quality assurance of an LDR implant,
and these were outlined in Chapters 4-7.
The primary method of source localisation in 3D was with the use of a multiple
pinhole collimator. In these feasibility studies, using a ray-tracing stereoscopic tech-
nique, LDR sources were found within 1-3 mm of expected positions. This is within
the accepted tolerance of implant position error according to the literature, there-
fore proving BrachyView’s efficacy as a real-time treatment visualisation system.
Furthermore, when compared with a clinical gold standard of a CT scan, it was fur-
ther determined that the results obtained with BrachyView were within 1-2 mm of
expected positions. This is in comparison with results typically taken from an in-
traoperative ultrasound scan, which is unable to determine source position with the
same accuracy.
Secondly, the possibility of applying BrachyView in CT imaging was investigated.
Using the in-body Timepix as the imaging plane, a full 3D reconstruction of sources
implanted in the phantom was obtained. However, because the imaging plane is
intrinsically smaller than the object to be imaged, the partial field of view presents
an obstacle to overcome. Using an iterative reconstruction algorithm (OSEM), it was
found that for a phantom study, a 3D reconstruction can yield CT results within 5
mm of expected positions.
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Lastly, BrachyView was tested as a diagnostic tool, in its ability to distinguish soft
tissue and therefore overcome conventional CT problems. Using standard X-ray
transmission techniques and a tissue-equivalent medical gel phantom, a BrachyView
prototype was tested. The Timepix detector has high resolution and high contrast
imaging properties, suggesting it is an appropriate detector for use in soft tissue
imaging applications.
The work done in developing the BrachyView system has been recognised in the
international brachytherapy community as a promising treatment option for prostate
cancer patients.
Several speaking engagements and outreach events both in Australia and abroad have
been presented highlighting BrachyView as a promising direction for prostate cancer
therapy. These included talks with high school, university students, and Rotary clubs.
On June 27, 2012, the BrachyView project was presented in the University-wide
speaking competition ’3 Minute Thesis’. The premise of the competition was to
present innovative research with an impact on society in three minutes or less to an
intelligent yet non-specialist audience. The talk was awarded best presentation at the
University of Wollongong, and was later commended at the Trans-Tasman finals held
at University of Queensland. These are outlined in detail in Section 1.2.
On May 22, 2013, the publication ”BrachyView: Proof-of-principle of a novel in-
body gamma camera for low dose-rate prostate brachytherapy” was featured as the
chosen ’Science Spark’ topic of the day at Memorial Sloan Kettering Cancer Care
Center in New York, USA. The image highlighted from the article was also featured
at the CyberLibrary Cafe in the Zuckerman Research Center.
BrachyView was also recently highlighted at the 2014 European BrachyPhys Task
Group (ESTRO) meeting ”Further potentials for high quality brachytherapy in the
future”. The American Brachytherapy Society meeting in Houston also recognised
BrachyView as one of the important highlights of the year out of all brachytherapy
projects in development.
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8.2 Future Work
While proof-of-concept of an in-body multifunctional probe was clearly demon-
strated, there are a number of considerations to improve and further the develop-
ment of BrachyView as a functional intraoperative treatment planning and imaging
system. While a lead collimator with 3-5 pinholes was suitable for feasibility stud-
ies, increasing the number of pinholes and optimising the field of view may enable
a higher accuracy in source localisation in 3D. Furthermore, the use of a tungsten
collimator has also been proposed as a further step in collimator design. However,
due to the technical requirements of machining a tungsten collimator, this has not yet
been experimentally verified. Additionally, further work with Monte Carlo methods
is recommended for optimising and characterising further pinhole geometries and
parameters of the BrachyView set-up. This is part of ongoing work conducted at
CMRP.
The identification of implanted brachytherapy sources on the imaging plane through
the pinholes has been done manually in this study. An automated system involves the
development of a software package that will not only identify the projection images,
but also perform the calculations to give the 3D coordinates of the implant. These
coordinates will then need to be compared to two things:
• Planned positions;
• Real-time patient anatomy changes.
This will need to be presented in a way that is easily comprehensible and operated
by brachytherapy practitioners and attending staff in the operating theatre during an
LDR procedure. As part of this software development, integration of the Pixelman
software has to be considered, in communicating with the Timepix detectors.
While the CT imaging as discussed in Chapter 6 presents a method of reconstructing
the LDR implant in full 3D, there are a number of technical issues that may present
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obstacles in a clinical scenario. These include introducing extra dose to the patient,
as well as uncertainties arising from the partial field of view problem. However,
as shown from the results from the pinhole measurements, BrachyView may in fact
supercede the need for CT imaging as a post-implant dosimetric tool, or at the very
least may be used as an additional, intermediate step for post-implant verification.
Lastly, the physical design of the BrachyView probe has to be finalised, along with
its integration with existing ultrasound hardware. However, as shown in this thesis,
the co-registration of such imaging datasets is relatively straightforward and can pro-
duce results that are both accurate, and clinically reliable. While BrachyView is to be
integrated into existing prostate brachytherapy hardware, the mechanical combina-
tion of the TRUS and Timepix detector apparatus is not imperative for the successful
application of BrachyView.
The prototype of the BrachyView system combined with the finalisation of imag-
ing software, will present an opportunity for brachytherapy practitioners to have a
real-time, dosimetric tool, able to localise implanted sources in 3D with sub-mm ac-
curacy. This ability to adjust implants as they occur will reduce localisation error and
therefore improve patient treatment outcome, thereby allowing a greater quality of
life for each patient affected by prostate cancer.
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